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ABSTRACT  
 
Introduction 
Cardiovascular disease is one of the leading causes of death in the world.  
Formation of harmful reactive oxygen species (ROS) is associated with 
several pathological conditions, and contributes to ischaemia/reperfusion 
injury.  Antioxidants can be added to the diet in an attempt to decrease the 
prevalence of cardiovascular disease by decreasing the harmful effects of 
ischaemia/reperfusion injury.   
 
Red Palm Oil (RPO) consists of saturated, monounsaturated and 
polyunsaturated fatty acids and is rich in antioxidants such as -carotene, 
tocopherols and tocotrienols. 
 
It has previously been shown that RPO-supplementation improved 
reperfusion mechanical function.  In these studies it was found that RPO 
might exert its beneficial effects during reperfusion through increased PKB/Akt 
pathway activity, which may lead to inhibition of apoptosis and improved 
mechanical function.   
 
Aims 
The aims of this study were:  1) to determine whether RPO-supplementation 
protected against ischaemia/reperfusion injury in the isolated perfused rat 
heart, 2) to confirm RPO-supplementation’s effect on the PKB/Akt pathway 
activity and, 3) to elucidate the regulators in the PKB/Akt pathway that RPO-
supplementation influenced.   
 
Methods 
Male Wistar rats were divided into 4 groups, 2 control groups and 2 
experimental groups.  The 2 control groups were fed a standard rat chow 
(SRC) for 4 weeks.  The two experimental groups received SRC and RPO-
supplementation for 4 weeks.  Hearts were excised and transferred to a 
Langendorff perfusion apparatus and perfused with Krebs-Henseleit buffer.  
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Mechanical functional recovery was measured after 25 min of total global no-
flow ischaemia.  The following parameters were also measured during various 
time points in the protocol:  left ventricular develop pressure, heart rate, 
coronary flow, rate pressure product.  Hearts were also freeze-clamped for 
biochemical analysis at 10 min during reperfusion.  The biochemical analysis 
was aimed at determining PKB/Akt involvement. 
In a second protocol, hearts were subjected to the same perfusion protocol, 
but wortmannin was also added to the perfusion fluid, in order to inhibit PI3-
kinase.   
 
Results 
Hearts from the RPO-supplemented rats showed an improved RPP recovery 
(92.26 ± 5.89 % vs 63.86 ± 7.74 %) after 10 min of reperfusion.  This finding 
corroborated the findings of previous studies.  Hearts of the RPO-
supplemented rats perfused with wortmannin, showed increased RPP 
recoveries at several time points. 
 
Biochemical results showed that wortmannin did indeed inhibit PI3-K 
phosphorylation in the RPO-supplemented group, as was expected.  The 
RPO-supplemented group that was perfused with wortmannin had an 
increased PKB/Akt (Ser473) phosphoyrylation, when compared to the 
wortmannin control group.  It was also found that the combination of RPO and 
wortmannin had prosurvival effects.   
 
Discussion 
This study showed that RPO-supplementation offered protection against 
ischaemia/reperfusion injury in the Langendorff-perfusion apparatus at 10 min 
into reperfusion. Thereafter the significance of the protection was lost.  This 
protection has been confirmed in several previous studies and several 
mechanisms have been proposed for this protection.     
Since no conclusive evidence exists on the precise mechanism of protection, 
our investigation focused on the regulators of the pro-survival PKB/Akt 
pathway.    
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An improved functional recovery was also seen in the RPO-supplemented 
group that was perfused with wortmannin.  This was an unexpected finding, 
because Wortmannin is a known PI3-kinase inhibitor (as was confirmed by 
our biochemical data).  PI3-kinase phosphorylation leads to PKB/Akt 
phosphorylation and therefore, activation of a pro-survival pathway.  It would 
be expected that wortmannin would inhibit PKB/Akt and thus decrease the 
survival of the cells.  The RPO-supplementation thus reversed wortmannin’s 
detrimental effect to such an extent that the functional recovery was far better 
than RPO-supplementation alone.   
 
In the RPO + wortmannin group, PKB/Akt (Ser473) phosphorylation was 
increased, contrary to previous findings.  This is an indication that RPO may 
have the ability to override wortmannin’s inhibitory effect on PI3-kinase, or 
that PKB/Akt (Ser473) may be phosphorylated independently of PI3-kinase.    
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OPSOMMING 
 
Inleiding 
Kardiovaskulêre siektes is een van die hoof oorsake van sterftes in die 
wêreld.    Die vorming van skadelike reaktiewe suurstof spesies word 
geassosieer met verskeie patologiese kondisies en dra ook by tot 
isgemie/reperfusie skade.  ‘n Moontlike manier om die voorkoms van 
isgemie/herperfusie skade asook kardiovaskulêre siektes te voorkom, is om 
antioksidante by die dieet te voeg.   
 
Rooi Palm Olie (RPO) bevat versadigde, mono-onversadigde en poli-
onversadigde vetsure.  RPO bevat ook ‘n oorvloed van antioksidante soos β-
karoteen en tokoferole en tokotriënole.   
 
Dit is bewys in vorige studies dat RPO-aanvulling verbeter funksionele 
herstel.  Hierdie voordelige effekte mag dalk wees agv verhoogde PKB/Akt 
pad aktiwiteit.  Die PKB/Akt pad word geassosieer met die inhibisie van 
apoptose en verhoogde meganiese funksie.   
 
Doelwitte 
Die doelwitte van hierdie studie was om te bepaal of 1) RPO-aanvulling 
beskermende effekte teen isgemie/herperfusie skade in die geisoleerde 
rotharte het, 2) Bevestig of RPO-aanvulling wel die PKB/Akt pad beïnvloed 3). 
om die  effekte wat RPO-aanvulling het op die reguleerders van die PKB/Akt 
pad te onthul.   
 
Metodes 
Manlike Wistar rotte is in 4 groepe verdeel.  2 Groepe kontrole rotte is ‘n 
standaard rotkosmengsel gevoer vir 4 weke.  Die 2 eksperimentele groepe 
het ook ‘n standaard rotkosmengsel gekry plus ‘n RPO-aanvulling vir 4 weke.  
Harte is uitgesny en op ‘n Langendorff perfusie sisteem gemonteer en met 
Krebs-Henseleit buffer geperfuseer.  Meganiese funksie herstel is gemeet na 
25 min totale globale geen-vloei isgemie.  Linker ventrikulêre ontwikkelde 
druk, harttempo, koronêre vloei en tempo druk produk is gemeet by 
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verskillende tydpunte.  Sommige harte is na 10 min herperfusie vir 
biochemiese analiese gevriesklamp.  Die biochemiese analisiese was beoog 
om die PKB/Akt pad betrokkenheid te bepaal.   
‘n Tweede stel harte is aan dieselfde perfusie protokol blootgestel, maar 
wortmannin (PI3-kinase inhibitor) is ook bygevoeg by die perfusie vloeistof. 
 
Resultate 
Die groep wat met RPO aangevul is, het na 10 min herperfusie, ‘n verbeterde 
tempo druk produk herstel getoon (92.26 ± 5.89 % vs 63.86 ± 7.74.  Hierdie 
bevinding is ook met ander studies bevestig.  ‘n Interessante bevinding was 
dat die groep wat met RPO aangevul is en met wortmannin geperfuseer is, ‘n 
verbeterde meganiese funksionele herstel getoon het. 
 
Biochemiese resultate het getoon dat wortmannin wel PI3-K fosforilering 
geinhibeer het.  Die harte van die rotte in die groep wat aangevul is met RPO 
en daarna met wortmannin geperfuseer is, het ‘n toename in PKB/Akt (Ser473) 
fosforilering getoon, relatief tot die wortmannin geperfuseerde harte van die 
rotte in die kontrole groep.  Hierdie groep (RPO-aanvulling en wortmannin 
perfusie) het beskermende effekte getoon. 
 
Bespreking 
Hierdie studie het getoon dat RPO-aanvulling beskerming gebied het teen 
isgemie/herperfusie skade in die Langendorff geperfuseerde rothart na 10 min 
herperfusie.  Daarna is die beduidenheid van die beskerming verloor.   Hierdie 
bevindings ondersteun die resultate van vorige studies.  Verskeie moontlike 
meganismes is voorgestel vir die beskerming, maar die presiese meganisme 
is nog nie duidelik nie. 
 
In hierdie studie is daar gekyk na die reguleerders van die PKB/Akt pad.  
Geen vorige studies het al gefokus op RPO-aanvulling en sy effek op die 
reguleerders van die PKB/Akt pad nie. 
 
‘n Onverwagte bevinding is dat harte van die rotte in die RPO + wortmannin 
groep ‘n verbeterde funksionele herstel getoon het.  Wortmannin is ‘n PI3-
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kinase inhibitor.  PI3-K fosforilering lei tot PKB/Akt fosforilering, wat tot sel 
beskerming lei.  Dus, aangesien wortmannin PI3-K inhibeer, sou dit verwag 
word dat wortmannin sel beskerming sal verminder.  Die RPO het egter die 
wortmannin se nadelige effekte tot so ‘n mate oorskrei dat die funksionele 
herstel baie beter was as die RPO-aanvulling alleen.   
Die verhoogde PKB/Akt (Ser473) fosforilering, wat gesien is in die RPO + 
wortmannin groep kan toegeskryf word aan RPO se vermoë om wortmannin 
se nadelige effekte te oorskrei.  ‘n Moontlike verduideliking vir hierdie 
bevinding mag wees dat rooi palm olie PKB/Akt (Ser473) op ‘n PI3-K 
onafhanklike manier fosforileer.   
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Chapter 1 INTRODUCTION 
1.1 Motivation for study 
 
Cardiovascular disease and heart failure is a leading cause of morbidity and 
mortality in industrialized countries (Ho et al., 1993), and is related to risk factors 
such as elevated blood pressure, cholesterol, or glucose levels and smoking 
(Yusuf et al., 2001.).  Recent studies have also suggested that the generation of 
reactive oxygen species (ROS) increased the incidence of heart failure (Belch et 
al., 1991; Hill and Singal, 1996; Mallat et al., 1998). 
The excessive formation of ROS has a harmful effect on the functional and 
structural integrity of biological tissue (McCord, 1985).  ROS have been 
implicated in a wide range of pathological conditions including 
ischaemia/reperfusion injury, neurodegenerative diseases and aging.  ROS 
cause contractile failure and structural damage in the myocardium.  However, 
their toxic effects can be prevented by scavenging enzymes known as 
antioxidants.   
It is thus clear that the prevention of ROS generation during 
ischaemia/reperfusion is increasingly important in ischamiea/reperfusin injury and 
heart failure prevention.  Antioxidants play an important role in minimizing the 
damaging effects of ROS generation and oxidative stress on cells (Rao et al., 
2006).  Dietary supplementation with a substance rich in antioxidants can be a 
means of preventing ischaemia/reperfusion injury, especially in heart failure.   
The carotenoids and vitamin E in RPO have strong antioxidant properties 
(Bagchi & Puri, 1998; Theriault et al., 1999) and can act as scavengers of 
damaging oxygen free radicals.  RPO also has a high content of SFAs, and this 
has created the perception that the oil may be detrimental to health.  However, 
the characteristic composition of the oil and the position of SFAs and MUFAs on 
the triaglyceride backbone make it unique (Kritchevsky, 2000; Ong and Goh, 
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2002).  Furthermore, a few studies have shown that RPO protected against 
ischaemia/reperfusion injury (Abeywardena et al., 1991; Charnock et al., 1991; 
Abeywardena & Charnock, 1995; Esterhuyse et al,. 2005).  Other evidence 
suggests that RPO protected against cardiovascular disease (Kritchevsky et al., 
1999) and may protect against cancer (Yu et al., 1999).   
Additional evidence is provided by studies in Africa and India where RPO-
supplementation improved vitamin A status in vitamin A deficient children that 
were either breastfed by mothers (Canfield et al., 2001) or received RPO in a 
spread applied to bread (Van Stuijvenberg, 2005).   
The precise mechanism of protection of RPO against ischaemia/reperfusion 
has not been resolved.  Esterhuyse et al. (2006) suggested that the NO-cGMP 
pathway is involved by offering protection during ischaemia.  Engelbrecht et al. 
(2006) showed that the PKB/Akt and MAPK pathways played a protective role 
during reperfusion.  However, no conclusive protective mechanism was 
described by any of these studies.   
When investigating the MAPK pathway, it was found that RPO might exert 
its beneficial effects through increased p38 phosphorylation and 
dephosphorylation of JNK (Engelbrecht et al., 2006).  Phosphorylation of p38 
protects the heart from ischaemia/reperfusion injury (Mackay and Mochly-Rosen, 
2000; Marais et al., 2001) and dephosphorylation of JNK appears to be anti-
apoptotic (Obata T et al., 2000; Park et al., 2000).  It was also found that RPO 
significantly increased phosphorylation of PKB/Akt (Engelbrecht et al., 2006).  
PKB/Akt activation promotes the survival of myocytes and protected against 
ischaemia/reperfusion injury (Fujio et al., 2000).   
Research has shown that RPO activated PKB/Akt (Engelbrecht et al., 
2006), but uncertainty prevails about the regulatory proteins that are involved.  
Therefore we were interested in studying the protective mechanism of RPO and 
how it relates to PKB/Akt pathway activity.   
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We used the Langendorff perfused heart model where hearts were 
subjected to ischaemia/reperfusion to investigate the effects of RPO on the 
function of the heart and regulators of PKB/Akt pathway at a cellular level.   
1.2 Aim 
The aims of this study were: 
1. to determine whether dietary Carotino Premium RPO-
supplementation protected against ischaemia/reperfusion in the 
isolated perfused rat heart 
2. to confirm that RPO-supplementation influenced the PKB/Akt 
pathway activity 
3. to determine upstream or downstream involvement of the PKB/Akt 
pathway with RPO-supplementation.   
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Chapter 2 LITERATURE REVIEW 
 
2.1 Introduction 
Cardiovascular disease (CVD) is one of the major causes of death in the 
Western world (Ho et al., 1993).  Risk factors which are associated with CVD 
include elevated blood pressure and glucose levels, as well as smoking (Yusuf et 
al., 2001).  Several studies also demonstrated that the generation of reactive 
oxygen species (ROS) are increased during heart failure (Belch et al., 1991; Hill 
and Singal, 1996; Mallat et al., 1998).   
The excessive formation of ROS and has a harmful effect on the functional 
and structural integrity of biological tissue (McCord, 1985).  These harmful effects 
of ROS can be prevented by scavenging enzymes that are known as 
antioxidants.  Antioxidants play an important role in attenuating the damaging 
effects of ROS on cells (Rao et al., 2006).   
The production of ROS is associated with ventricular function impairment, 
arrhythmias and coronary dysfunction during ischaemia/reperfusion injury (Bolli, 
1991; Cai & Harrison, 2000; Toufektsian et al., 2001). In trying to prevent the 
increasing prevalence of heart failure, it is thus important to decrease the extent 
of ischaemia/reperfusion injury.     
2.2 Ischaemia/reperfusion injury in the rat heart 
Ischaemia/reperfusion injury occurs when blood flow to the heart is 
disrupted and then subsequently reintroduced. In this situation much of the 
damage occurs during the reperfusion period, when blood flow is restored after 
coronary occlusion. A primary factor in the initiation of the pathological response 
to reperfusion injury is the generation of ROS, which can covalently modify 
protein and lipid macromolecules, leading to cell damage, DNA mutation and 
initiation of the necrotic and apoptotic cascades (Li & Jackson, 2002).  
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Furthermore, there is also a restriction of oxygen to the heart during an 
ischaemic episode.  This restriction of oxygen leads to an accumulation of lactate 
and protons.   This build-up is due to the uncoupling of glycolysis from glucose 
oxidation and continued H+ production during ischaemia (Liu et al., 1996), which 
results in a decrease in intracellular pH.  The accumulation of protons and lactate 
is detrimental to heart function and the magnitude of the pH decrease determines 
the severity of the ischaemic episode (Kloner & Jennings, 2001; Liu et al., 2002).   
If the ischaemic episode is not too severe, injury to the myocardium can be 
reversed during reperfusion.  Fatty acid oxidation rapidly recovers during 
reperfusion.  Even though fatty acid oxidation is restored, the uncoupling of 
glycolysis form glucose oxidation still occurs during reperfusion.   The proton 
accumulation that is associated with ischaemia and reperfusion is detrimental to 
the normal heart function as it potentially leads to an accumulation of intracellular 
Ca2+ during reperfusion (Liu et al., 1996; Du Toit et al., 2001), which is 
detrimental to the heart.  Furthermore, it was shown by Liu et al., (1996) that a 
sudden rise in intracellular Ca2+ could potentially cause cell death.   
Proton accumulation also results in impaired functional recovery during 
reperfusion and a reduction in cardiac efficiency (cardiac work/myocardial O2 
consumption).  H+ production can be decreased by improving glycose to glycose 
oxidation coupling.  This decrease in H+ production and/or inhibiting Na+/H+ 
exchange, can improve functional recovery as well as cardiac efficiency during 
reperfusion (Liu et al., 1996).  It can thus be seen that the altered metabolism of 
the heart during ischaemia/reperfusion contributes to cell death which is 
responsible for the impaired functional recovery of the post-ischaemic heart. 
2.3 Apoptosis during ischaemia/reperfusion-
induced injury 
The significance of cell death by apoptosis during ischaemia/reperfusion 
injury has gained great interest and unlike necrosis, which is thought to be an 
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essentially irreversible process, the step-by-step nature of apoptosis suggests 
that it may be amenable to therapeutic intervention.  
Apoptosis (programmed cell death) is essential to many biological 
processes including embryonic development, immune responses, tissue 
homeostasis and normal cell turnover (Lin, 2003).  It has been shown that 
apoptosis plays a significant role in myocardial ischaemia/reperfusion injury 
(Kajstuara et al., 1996).  The increase in the amount of oxygen free radicals 
during reperfusion can account for the increased apoptosis in cell culture and the 
isolated perfused heart (Feuerstein and Young, 1999). 
Apoptosis is an active mode of cell death where the cell itself designs and 
executes the program of its own death.  There are several regulatory systems, 
which include the Bcl-2/bax family of proteins (Hockenberry, 1995; Reed, 1994), 
the cysteine-proteases (caspases) (Fernandes-Alnemri et al., 1995; Lazebnik et 
al., 1994; Nicholson et al., 1995) and possibly also serine- proteases (Bruno et 
al., 1992; Hara et al., 1996; Weaver et al., 1993). 
The release of cytochrome c from the mitochondria is an important event in 
apoptosis.  Cytochrome c release triggers the activity of caspases and other 
downstream apoptotic effectors (Chinnaiyan et al., 1996; Wu et al., 1997; Yang 
et al., 1997, Kluck et al., 1997).  
2.3.1  The molecular pathways through which apoptosis is induced 
The activation of cysteine proteases (caspases) is one of the biochemical 
features of apoptosis (Lazebnik, 1998).  Caspases are present in cells as inactive 
procaspases that can be cleaved and activated in response to an apoptotic 
stimulus. The activation of caspases can follow two routes. The first one being 
the transduction of a signal from the membrane death receptors (Ashkenazi & 
Dixit, 1998).  Stimulation of the death receptors lead to the activation of caspase-
8, which further activates caspase-3, a key protein in apoptosis. The second 
pathway for activation is mediated through a mitochondrial pathway (Green & 
Stellenbosch University  http://scholar.sun.ac.za 
  7
Kroemer, 1998).  Cytochrome c is released from the mitochondria, which leads to 
activation of caspase-9 and subsequent activation of caspase-3. 
Apoptosis is energy dependent and highly regulated and is controlled by 
the complex interaction of numerous pro-survival and pro-death signals. These 
regulatory proteins include the Bcl-2 family of proteins which exert their effects 
mainly through the mitochondria.  This family of proteins can be anti-apoptotic 
(Bcl-2, Bcl-XL) or pro-apoptotic (Bad, Bid) (Adams & Cory, 1998). Other important 
regulators of apoptosis act at the level of caspases. These include cellular 
FADD-like inhibitory protein (cFLIP) and the inhibitor of apoptosis (IAP) family 
(Schmitz et al., 2000).   
There are also several other factors that are involved in the regulation of 
apoptosis.  These include, growth factors, mitogen activated protein kinases 
(MAPKs), PKB/Akt, calcium, and oxidants. The outcome of the interaction of all 
these molecules determines the fate of the cell: life or death.  
2.3.2 Caspases and the apoptotic pathway 
An essential phenomenon of apoptotic cell death is the activation of 
caspases.  Caspases are a unique class of aspartate-specific proteases.  As 
many as 14 members have been identified (Nicholson & Thornberry, 1997).  All 
of the caspases are composed of a prodomain and an enzymatic region.  
Differences among the proteases can be seen, regarding the structure of the 
prodomain.  This region defines functional differences between caspases.  
Caspase-1, -2, -4, -5, -8, -9, and -10 contain a long prodomain versus caspases-
3, -6, and -7, which contains a much shorter prodomain.  For caspases to be 
activated, the proform has to be cleaved within the enzymatic domain.  Activation 
can only occur through auto activation or cleavage by other caspases.   
Caspases may work in a cascade fashion.  It was found that deletion of 
caspase-3 resulted in failure of neural apoptosis.  These mice were born with 
overlarge brains and they die soon after birth (Kuida et al., 1996). 
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There are many different proteins that act as substrates for caspases.  
These include nuclear proteins, proteins involved in signal transduction, and 
cytoskeletal targets (Cardone et al., 1997; Kothakota et al., 1997; Sakahira et al., 
1998).  Most of these proteins appear to be cleaved by caspases-3 and -7.  
Before apoptosis can take place, there must be a cleavage of a cytoplasmic 
inhibitor of the apoptosis-specific endonucleases (Enari et al., 1998; Sakahira et 
al., 1998; Liu et al., 1997).  Only after this cleavage, the endonuclease 
translocate to the nucleus and degrade the genomic DNA (Enari et al., 1998; 
Sakahira et al., 1998).  Thus, the activity of caspases-3 and -7 leads to the 
breakdown of cellular target proteins. 
2.3.3 PARP 
One of the targets of caspases is the enzyme poly-(ADP-ribose) 
polymerase (PARP).  The cleavage of PARP by caspase-3 during apoptosis 
facilities nuclear disassembly and may help to ensure the completion of 
apoptosis (Szabo, 2005).  It has been postulated that PARP cleavage occurs in 
order to prevent depletion of energy pools required for later stages of apoptosis 
(Earnshaw, 1995). Oliver and co-workers (1999) also claim that PARP cleavage 
facilitates cellular disassembly, ensuring cell death completion. 
In contrast to PARP cleavage, PARP activation induces necrotic cell death. 
The obligatory trigger for its activation is nicks and breaks in the DNA strand. The 
generation of free radicals and oxidants in cardiac myocytes during 
ischaemia/reperfusion leads to such DNA strand breakage. This initiates an 
energy consuming and inefficient metabolic cycle with transfer of the ADP-ribosyl 
moiety of NAD+ to protein acceptors. Resynthesis of NAD+ requires ATP and 
poses a heavy demand on the cellular energy capacities. Failure to overcome 
this crisis leads to cell death, apoptotic or necrotic, depending on ATP 
availability.  In this way, ATP is rapidly diminishing and its usage for other 
processes, including apoptosis is prevented. Therefore, the energy depletion 
caused by PARP activation induces rapid necrotic rather than delayed apoptotic 
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cell death.  In other words, PARP activation shifts cellular death towards 
necrosis, away from apoptosis. In this way PARP may prevent several damaged 
cells from attempting to repair themselves and surviving with a high mutation 
frequency (Martin et al., 2005).  
 
2.4 Signalling pathways and apoptosis in the heart 
2.4.1 Introduction 
Several efforts have been made to disentangle the intricate relationships 
between signal transduction and apoptosis.  Analysis is complicated by the fact 
that receptor agonsits may activate several signal transduction mechanisms with 
opposing effects on apoptosis regulation.  However, it has become clear that the 
PKB/Akt signalling pathway plays a major role in the regulation of apoptosis in 
the heart. 
2.4.2 Protein kinase B (PKB)/Akt pathway (Fig 2-1) 
The serine/threonine protein kinase, protein kinase B or Akt (PKB/Akt), is an 
important regulator of many cellular processes.  These processes include 
apoptosis, proliferation and differentiation.  Three members of the PKB/Akt family 
have been isolated.  They are PKB (Akt1), PKB (Akt2), and PKB (Akt3).  
These members show an 80% homology in their amino acid composition.   
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 Figure 2-1:  The PKB/Akt pathway   
PKB/Akt is a downstream target for (phosphatidylinositol 3-kinase) PI3-K 
(Burgering & Coffer, 1995; Franke et al., 1995).  For the activation of PKB/Akt to 
take place, inositol-containing membrane lipids must be phosphorylated by PI3-
K.  Factors that stimulate PI3-K to phosphorylate these lipids include thrombin, 
platelet-derived growth factor, and insulin (Downward, 1998).  There has been 
speculation about other pathways leading to activation of PKB/Akt 
(Vanhaesebroeck & Alessi, 2000), but the identity of these pathways remain 
unclear.  One mechanism considered is the activation of PKB/Akt by heat shock 
and oxidative stress (Konishi et al., 1996; Shaw et al., 1998).  
PI3-K is activated by tyrosine kinases and G-protein coupled receptors.  
Activated PI3-K then phosphorylates phosphatidylinositol-4,5-bisphosphate 
(PIP2).  This generates the second messenger phosphatidylinositol-3,4,5-
trisphosphate (PIP3).  PIP3 levels are regulated by phosphatases such as PTEN 
and SHIP.  PTEN removes phosphate from the 3-OH position and SHIP 
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dephophorylates at the 5-OH position.  These phosphatases thus inhibits the 
generation of the second messenger. 
 PIP3 does not activate PKB/Akt directly.  PIP3 recruits PKB/Akt to the plasma 
membrane and alters PKB/Akt’s conformation so that phosphorylation can take 
place by phosphoinositide-dependent kinase-1 (PDK-1). 
PDK-1 is a 63-kDa serine/threonine kinase that contains a C-terminal PH 
domain that binds with high affinity to 3-phosphoinositides.  PDK-1 
phosphorylates PKB/Akt.  This regulates access to the catalytic site of PKB/Akt, 
where phosphorylation in vitro is enhanced by 3-phosphoinositides.  This 
phosphorylation takes place at the Thr308 site of PBK/Akt.  It has been suggested 
that lipids induce both a favourable conformation of PKB/Akt as well as PDK-1.  
This allows access to the acceptor phosphorylation site (Alessi et al., 1997; 
Stokoe et al., 1997). 
The phosphorylation at Thr308 partially activates PKB/Akt (Alessi et al., 
1996).  For full activation, phosphorylation must also take place on Ser473. 
Phosphorylation of Thr308 alone is able to increase PKB/Akt activity, while the 
phosphorylation of Ser473 alone does not stimulate the kinase (Alessi et al., 1996; 
Bellacosa et al., 1991) 
In most situations, phosphorylation of PKB/Akt at Ser473 occurs together 
with Thr308 (Alessi et al., 1996), but some studies have shown that 
phosphorylation at the two sites occur independently (Kroner et al., 2000).  PDK-
1 null embryonic stem cells maintain the ability to undergo Ser473 phosphorylation 
(Williams et al., 2000). However, the regulation of PKB/Akt is a complex process, 
but it is clear that the phosphorylation of Ser473 alone does not increase PKB/Akt 
activity.   
There is increasing evidence that the PKB/Akt pathway participates in 
ischaemia/reperfusion-induced injury (Brar et al., 2002; Andreucci et al., 2003). 
Expression of active PI3-kinase itself is cardioprotective (Brar et al., 2002).  This 
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finding is consistent with a number of studies where the activation of PI3-kinase 
prevented ischaemic- (Matsui et al., 1999; Fujio et al.,  2000) and 
ischaemic/reperfusion induced cell death of cardiac myocytes (Fujio et al.,  
2000).  
One of the substrates of PKB/Akt, glycogen synthase kinase (GSK), also 
play a pivotal role in ischaemia/reperfusion injury. GSK is an unusual protein 
because its kinase activity is high under basal conditions, and stimuli result in its 
inactivation.  Also, many of GSK’s substrates are functionally inhibited by 
phosphorylation.  This means that signals that inhibit or inactivate GSK-3 often 
cause activation of its downstream target proteins (Kockeritz et al., 2006; Cross 
et al., 1995). 
GSK-3 has two isoforms,  (51kDa) and  (47kDa), and they are 
characterized as serine/threonine kinases.  These two isoforms have a 98% 
identity in their central 30-kDa catalytic domain (Woodgett, 1990; Juhaszova et 
al., 2004).  These isoforms exhibit different catalytic activities toward different 
intracellular substrates.  The  isoform has a higher activity than the  isoform 
(Plyte et al., 1992).  GSK is a pivotal kinase as it receives inputs from different 
pathways that regulate its enzymatic activity.  GSK-3 is involved in the control of 
a variety of cellular processes through several intracellular signalling pathways.  
The most important role of GSK-3 is that it phosphorylates and inactivates 
glycogen synthase (Rylatt et al., 1980; Plyte et al., 1992). 
Cardioprotection may be mediated by the phosphorylation of GSK-3 
(Juhaszova et al., 2004). Gross et al (2004) showed that the addition of GSK-3 
inhibitors before the start of reperfusion resulted in a significant reduction in 
infarct size.  Tong and co-workers (2002) also demonstrated that inhibition of 
GSK-3 reduced infarct size and improved post-ischaemic function. 
 GSK-3β is a substrate of PKB/Akt and also participates in regulating the 
cell cycle in various cell types (Liang and Slingerland, 2003).  PKB/Akt 
phosphorylates GSK-3β at Ser9.  The phosphorylation decreases the activity of 
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the enzyme.  This leads to reduced glycogen synthase phosphorylation at the 
sites phosphorylated by GSK-3 and also mediates insulin-stimulated upregulation 
of glycogen synthase activity (Cross et al., 1995; McManus et al., 2005; Kerr et 
al., 2006).  PTEN increases GSK-3 activity by exerting an inhibiting effect on 
PKB/Akt (Persad et al., 2001; Sharma et al., 2002). 
2.4.3 Involvement of PKB/Akt in anti-apoptotic mechanisms  
All cells have the intrinsic capacity to undergo apoptosis.  This capacity is 
suppressed by survival signals.  Several studies have shown that PKB/Akt is 
critical for cell survival.  These studies showed that there is a reduction in the 
ability of growth factors to maintain cell survival in the absence of activated 
PKB/Akt. Furthermore, cells can be rescued from stress-induced apoptosis when 
there is an overexpression of activated PKB/Akt (Kauffmann-Zeh et al., 1997; 
Kennedy et al., 1997; Khwaja et al., 1997; Kulik et al., 1997). 
It is clear that PKB/Akt promotes cell survival, but the mechanisms involved 
are not yet clear. There are several PKB/Akt substrates.  Some of these either 
participate directly in the apoptotic cascade or regulate the transcription of pro- 
and anti-apoptotic genes. Prosurvival substrates of PKB/Akt signaling include 
ASK1, BAD, CREB, Forkhead family (FKHR, FKHRL1, AFX), NF-B kinase and 
procaspase-9. 
A way in which PKB/Akt might promote cell survival is through the direct 
phosphorylation of transcription factors controlling the expression of pro-and anti-
apoptotic genes.  PKB/Akt inhibits the pro-apoptotic genes and stimulates the 
survival genes.  Although not directly, PKB/Akt exerts these effects on factors 
that influence these genes.  An example where PKB/Akt negatively regulates the 
apoptotic genes is on the forkhead family of transcription factors.  There are 
three identified mammalian members of the forkhead family, FKHR, FKHRL1, 
and AFX.  All of these members contain a PKB/Akt phosphorylation sequence 
that can be phosphorylated by PKB/Akt in vitro (Biggs et al., 1999; Brunet et al., 
1999; Rena et al., 1999).  The phosphorylation of forkhead proteins by PKB/Akt 
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alters their location in the cell.  When PKB/Akt activity is increased, it leads to the 
export of FKHRL1 from the nucleus (Biggs et al., 1999).  The forkhead proteins 
are not able to influence the forkhead genes, located in the nucleus, to transcribe 
pro-apoptotic proteins.  Thus, PKB/Akt negatively regulates forkhead activity. 
 
PKB/Akt also regulates other transcription factors:  NF-B has survival-
promoting activity.  PKB/Akt is a critical regulator of NF-B-dependent gene 
transcription and may play a critical role in promoting cell survival (Romashkova 
& Makarov, 1999; Ozes et al., 1999).  PKB/Akt is also involved in the expression 
of the anti-apoptotic gene bcl-2 (Skorski et al., 1997; Pugazhenthi et al., 2000).  
PKB/Akt is believed to increase its expression.  It has been found that PKB/Akt 
also plays a role in the regulation of the expression of c-FLIP (Panka et al., 
2001).  C-FLIP is a caspase-8 homologue that acts as a negative inhibitor of TNF 
receptor family-induced apoptosis.   
PKB/Akt also phosphorylates and deactivates pro-caspase-9, thus inhibiting 
the apoptotic pathway (Cardone et al., 1998). 
PKB/Akt not only influences the expression of proteins at the gene level, but 
can also promote survival by directly phosphorylating key regulators of the 
apoptotic cascade.  BAD is a member of the Bcl-2 family that promotes apoptosis 
by binding to prosurvival members of the same family and antagonizing their 
actions.  PKB/Akt phosphorylates BAD which leads to the sequestration of BAD 
in the cytosol, thus preventing BAD from interacting with the prosurvival genes at 
the mitochondrial membrane (Del Peso et al., 1997; Datta et al., 1997).  PKB/Akt-
induced phosphorylation of BAD may also occur indirectly through the enhanced 
expression of active Raf-1 on the mitochondrial membrane. (Majewski et al., 
1999; Shurmann et al., 2000; Tang et al., 2000).   
All these findings indicate that PKB/Akt regulates apoptosis prior to the 
release of cytochorme c from the mitochondria.  However, it was also found that 
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PKB/Akt can influence postmitochondrial events of apoptosis (Cardone et al., 
1998; Zhou et al., 2000). 
 
2.4.4 Negative regulation of PKB/Akt activity 
The activity of PKB/Akt depends on the balance between the signals that 
activates PKB/Akt (like PIP3) and the signals that negatively regulate PKB/Akt 
(dephosphorylation of PKB/Akt) (Andjelkovic et al., 1996; Meier et al., 1997, 
1998). 
A decrease in PI3-K activation leads to a rapid dephosphorylation of Ser473 
and a slower dephosphorylation of Thr308.  This dephosphorylation causes a loss 
of PKB/Akt activity.  PKB/Akt can also be inactivated by ceramide (Schubert et 
al., 2000) and osmotic stress (Meier et al., 1998; Chen et al., 1999) through the 
dephosphorylation of Ser473.  The dephosphorylation of Thr308 can occur 
independently of Ser473 (Schubert et al., 2000) and a recent study also indicates 
that PDK-1 might participate in this dephosphorylation, but the mechanism is still 
unknown (Yamada et al., 2001).  Thus, PDK-1 might be involved in 
phosphorylating and dephosphorylating of PKB/Akt. 
PTEN can dephosphorylate the inositol ring of the second messenger 
phosphatidylinositol (3,4,5)-triphosphate (PIP3), thus inhibiting cell survival due to 
responses from PI3-kinase and PKB/Akt (Maehama and Dixon, 1998; Stambolic 
et al., 1998; Wu et al.,1998).  The overexpression of PTEN significantly reduced 
the PI(3,4,5)P3 production which was induced by insulin.  It was also found that 
PTEN-null cells have higher levels of PI(3,4,5)P3 (Haas-Kogan et al., 1998; 
Maehama & Dixon, 1998; Stambolic et al., 1998).  Thus, it is clear that PTEN 
inhibits PI3-kinase activity, thereby influencing PKB/Akt activity.  Experiments 
conducted with inactive PTEN and PTEN-null fibroblasts showed that these cells 
exhibit high basal activity of PKB/Akt (Meyers et al., 1998; Li & Sun, 1998; Wu et 
al., 1998).  Genetic studies done in C elegans indicated that PTEN lies in the 
same pathway as PI3-kinase/PKB and inhibits PKB/Akt (Ogg & Ruvkun, 1998).  
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All of the above mentioned studies confirmed PTEN’s ability to negatively 
regulate PKB/Akt. 
SHIP is another lipid phosphatase that can negatively regulate PKB/Akt.  
The over-expression of SHIP has been shown to inhibit PKB/Akt activity and 
SHIP-null cells induced prolonged activation of PKB/Akt upon stimulation (Liu et 
al., 1995; Aman et al., 1998).  
It is clear from the previously discussed pathways that apoptosis is a highly 
regulated and complex process, controlled by numerous checkpoints and 
signalling networks.  This is of particular importance in fully differentiated 
cardiomyocytes where it prevents unnecessary death of salvageable cells. 
Although the extent to which apoptosis is involved in cardiac disease remains to 
be established, the evidence that has emerged clearly supports a role for this 
mode of cell death. A better understanding of the underlying pathways may lead 
to the development of therapies to treat coronary heart disease (CHD) which are 
anti-apoptotic with minimum or no side effects.  
 
2.5 Lipids in cardiovascular health 
The concept that dietary lipids affect the incidence of CHD is widely 
accepted, based on both epidemiological and experimental evidence. Lipids, 
which refer to both fats and oils (fats refer to lipids that are solids at room 
temperature while oils are usually liquids at room temperature), form an 
important part of our diets and are also essential for cardiovascular health.  They 
provide calories for metabolic activities, supply essential fatty acids and assist in 
the absorption of fat-soluble vitamins.  Lipids are also required for cell structure 
and membrane function.  Lipid components like cholesterol and phospholipids 
regulate membrane-associated functions such as activities of membrane bound 
enzymes, receptors and ion channels (Clandinin et al., 1991).  Lipids are thus 
important and essential in our every day life. 
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Dietary lipids consist of triglycerides (esters of glycerol and the three fatty 
acids) and minor amounts of phospholipids and sterols.  The most common 
sources of lipids derived from plants are: soybean oil, palm oil, sunflower seed oil 
and rapeseed oil (Ong & Goh, 2002).  The fatty acid composition of the most 
important oils and fats are summarized in Table 1.  These are classified 
according to degree of saturation, into saturated fatty acids (SFAs), 
monounsaturated fatty acids (MUFAs) and polyunsaturated fatty acids (PUFAs). 
SFAs are straight chain structures with no double bonds and an even 
number of carbon atoms.  Human MUFAs have an even number of carbon 
atoms, a chain length of 12-22C and a double bond with the cis configuration.  
PUFAs are mostly confined to the C18 and C20 acids, and have more than one 
double bond.  PUFAs are further divided into omega-6 (-6) or omega-3(-3) 
fatty acids based on the position of the first double bond nearest to the methyl 
end of the carbon chain.   
 
2.6 Red Palm Oil as a therapeutic agent for 
cardiovascular disease 
2.6.1 Introduction 
Palm oil is the second most commonly consumed vegetable oil in the world 
(Edem, 2002) and is mainly used as an edible oil. Crude palm oil is obtained from 
the fruit of a tropical plant, Elais guineensis (Manorama et al., 1993; Nagendran 
et al., 2000), and is grown in India, Malaysia and in some African countries 
(Hariharan et al., 1996).  The use of palm oil dates back as far as 5 000 years. 
The palm tree bears 10-12 fruit bunches annually, each weighing between 20-30 
kg.   
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Table 2-1:  Saturated, monounsaturated and polyunsaturated fatty acid 
composition of dietary oils and fats (Ong & Goh, 2002). 
Oil SFA (%) MUFA (%) PUFA(%) 
P/S 
ratio 
U/S 
ratio 
Rape seed 5 71 24 4,8 19 
Canola 7 61 32 4,67 13,3 
Sunflower 11,7 18 68,6 5,9 7,4 
Olive 13 79,1 7,9 0,6 6,7 
Corn 13,3 28,4 58,3 4,4 6,5 
Soybean 16 23,5 60,5 3,8 5,3 
Groundnut 20 38,7 41,3 2,1 4 
Cotton seed 27,7 19,8 52,5 1,9 2,6 
Lard 43 47 10 0,2 1,3 
Palm olein 46,8 41,5 12 0,3 1,1 
Palm oil 49,5 40,3 9,6 0,2 1 
Red palm oil 50,8 38,3 10,9 0,2 1 
Cocoa butter 60 36,5 3,4 0,2 0,7 
Butter 63,4 32,5 4,5 0,1 0,6 
Hydrogenated soybean 64 + trans 26 4 0,1 0,5 
Palm kernel 84 14 2 0,02 0,2 
Coconut 92,2 6,2 1,6 0,02 0,1 
P/S:  Polyunsaturated/saturated fatty acid ratio.  U/S:  monounsaturated + polyunsaturated/saturated 
fatty acid ratio.  P2, S2, U2:  polyunsaturated, saturated and total unsaturated fatty acids, respectively, at 
position sn-2 of the triacylglycerol molecule. 
(reproduced from Ong and Goh, 2002) 
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2.6.2 Composition of Red Palm Oil 
Crude palm oil consists mainly of glycerides and small quantities of non-
glyceride components.  These non-glyceride components include free fatty acids, 
trace metals, moisture and impurities, as well as minor components.  The minor 
components include some of the most important components of crude palm oil.  
They are carotenoids, tocopherols and tocotrienols (Goh et al., 1985).   
Together, these components contribute to the stability and nutritional 
properties of crude palm oil (Ooi et al., 1996).  RPO consist of 51 % SFAs, 38 % 
MUFAs, 11 % PUFAs (Table 1) and contains 500 parts per million (ppm) 
carotenoids, 60 % as -carotene and 25 % as -carotene.  The vitamin E content 
of RPO is between 500 - 800 ppm.  Of the total vitamin E, 70 % is tocotrienols 
and 30 % tocopherols (Nagendran et al., 2000; Sundram et al., 2003).  RPO also 
contains small amounts of CoQ10.   
The carotenoids are precursors of vitamin A.  Drummon & Coward 
observed in 1920 that the red palm oil pigment was largely carotene and that it 
possessed vitamin A activity in rats (Aykroyd & Wright, 1937).  The tocopherols 
and tocotrienols are vitamin E isomers and are potent antioxidants (Nagendran et 
al., 2000).    
Crude palm oil is not very stable.  Due to some of the non-glyceride 
components, the oil needs to undergo a refining process during which the oil is 
rendered stable. Unfortunately the refining process also results in both the 
removal of some of the tocopherols and tocotrienols and the destruction of all the 
carotenoids present.  This is how carotenoid-free palm oil is produced.  A 
modified refining process has thus been developed to decrease the loss of 
carotenoids.  The product is a stable, red palm oil that retains at least 80 % of the 
carotenoids and the vitamin E that is originally found in crude palm oil. The oil 
contains just over 500 ppm carotene, 85 % of which is present as - and -
carotene.  This makes it the world’s richest food source of carotenoids.  It is also 
a very good source of vitamin E (30 % tocopherols & 70 % tocotrienol) (Sundram 
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et al., 2003).  Ubiquinones and sterols are also other important minor 
components present in the oil (Nagendran et al., 2000).  Red palm oil is a non-
genetically modified, cholesterol-free and trans fatty acid free oil (Goh et al, 1985; 
Sundram et al, 2003).  The RPO that was used in this study is commercially 
available Carotino Premium, and its components are provided in Table 2-2.  
The saturated fatty acids of red palm oil consist of palmitic acid (44 %) and 
stearic acid (5 %), while the UFAs are oleic acid (39 %) and linoleic acid (10 %) 
(Ong and Goh, 2002).  The SFA and UFA are evenly distributed in RPO.  
 
 
Table 2-2: The components of Carotino Premium red palm oil (per 100 ml). 
Total fats 92 g 
         Monounsaturates 43 g 
         Polyunsaturates 12 g 
          Saturates 37 g 
          Trans fat 0 g 
Cholesterol, Sodium 0 g 
Protein, Carbohydrate, Dietary fibre 0 g 
Natural Carotenes 46 mg 
Natural Vitamin E 74 mg 
Co-Enzyme Q10 4 mg 
(reproduced from Premium Carotino Palm fruit oil label)  
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2.7 Protection provided by the individual 
components of Red Palm Oil 
2.7.1 Fatty acids  
The type of dietary fat influences the serum lipid concentrations (Idris & 
Sundram, 2002) as well as the incidence of coronary heart disease (CHD).   
Dietary saturated fatty acids cause an elevation in plasma cholesterol 
levels.  Saturated fatty acids have been positively implicated in raising plasma 
total cholesterol (TC) and low density lipoprotein (LDL) cholesterol, and 
enhances the risk for coronary heart disease (CHD) (Idris & Sundram, 2002).  
Saturated animal fats also increase the susceptibility to develop cardiac 
arrhythmias under ischaemic stress (Charnock et al., 1991).  Therefore, it is not 
recommended to consume saturated fats, as they are linked to an unhealthy 
cholesterol and cardiovascular status (Kritchevsky, 1995).   
It is generally acknowledged that increasing PUFA intake and reducing the 
intake of saturated fats exert a beneficial effect on plasma cholesterol levels 
(Hegsted et al, 1965; Keys et al, 1965).  It has been shown that when saturated 
fatty acids, e.g. palmitic acid, is substituted with a monounsaturated fatty acid, 
e.g. oleic acid, and a polyunsaturated fatty acid, e.g. linoleic acid, the plasma TC 
as well as plasma LDL-C was significantly reduced (Mattson & Grundy, 1985).  It 
is clear from the literature that different dietary saturated fatty acids do not exert 
the same detrimental cholesterolaemic impact, e.g. lauric acid (12:0), myristic 
acid (14:0) and palmitic acid (16:0) were found to be equally detrimental (Keys et 
al, 1965).  Furthermore, Hegsted et al. (1965) have shown that lauric acid and 
myristic acids are more hypercholesterolaemic than palmitic acid.  Of these, 
lauric acid was found to be the most hypercholesterolaemic (Denke & Grundy, 
1992). Stearic acid (18:0) was found to be relatively neutral (Hegsted et al, 1965; 
Keys et al, 1965) or even hypocholesterolaemic in some studies (Horlick & Graig, 
1957; Denke & Grundy, 1992; Bonanome & Grundy, 1988).  This implies that 
lauric, myristic and palmitic acids are the saturated fatty acids that can raise 
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cholesterol levels, with palmitic acid being less adverse than the other two.  
Hayes et al. (1991) also showed that palmitic acid as a component of palm oil 
failed to raise cholesterol levels. 
  The question can thus be raised as to why the other long-chained 
saturated fatty acids showed a cholesterol-raising effect and not stearic acid.  
The answer might lie in a process that occurs shortly after absorption.  Stearic 
acid is desaturated to oleic acid, which does not raise cholesterol concentrations 
(Elovson, 1965).  Lauric acid, on the other hand, presumably retains its status as 
a saturated fatty acid and exerts its cholesterol-raising properties (Brett et al, 
1971).  There is thus an overall misconception that all saturated fatty acids are 
detrimental to health. 
Polyunsaturated fatty acids reduce the plasma cholesterol levels when they 
are exchanged for saturated fatty acids. It is recommended that PUFAs should 
be increased and SFA are decreased in the diet.  This would lower serum 
cholesterol and indirectly prevent atherosclerosis (Heyden, 1994).  It is not clear 
whether this increase in PUFA consumption is really as good for health as is 
expected (Sturdevant et al, 1973; Shepherd et al, 1978; Vessby et al, 1980; Vega 
et al, 1982), despite the decrease in serum cholesterol that is associated with an 
increase in PUFA.  
Fats that have a high PUFAs content are more susceptible to oxidation than 
SFAs.  In the absence of adequate antioxidants, PUFAs will increase the 
oxidative stress in the heart and contribute to dysfunction and myocardial 
damage by increasing cardiac susceptibility to lipid peroxidation (Mehta et al., 
1994; Esposito et al., 1999; Hart et al., 1999; Droge, 2002; Faine et al., 2002; 
Novelli et al., 2002; Diniz et al. 2004).  The number of double bonds of a fatty 
acid determines the inclination with which the fatty acid is peroxidized.  As 
PUFAs have more than one double bound, it has a higher rate of peroxidation, 
and without adequate antioxidants, this can be deleterious.  From the above 
Stellenbosch University  http://scholar.sun.ac.za 
  23
mentioned studies, it is thus clear that increased concentrations of  PUFAs in the 
diet is not necessarily as healthy as is generally accepted.   
On the other hand, monounsaturated fatty acids appeared to be neutral.  It 
was found by Sundram and co-workers (1995) that the substitution of dietary 
palmitic acid with monounsaturated oleic acid (C18:1n-9) did not result in 
significant differences in plasma TC.  These results are in agreement with 
previous studies (Vergroesen & Gottenbos, 1975; Ng et al., 1992; Ghafoorunissa 
& Reddy, 1993).  When comparing a diet high in PUFA with a diet high in MUFA, 
no significant differences were found in the high density lipoprotein (HDL) 
cholesterol levels (Fernandez & McNamara, 1989; Berry et al., 1991).  
The effects of the different fatty acids in diets are well researched, but it can 
be concluded from the above mentioned studies that not all saturated fats are 
equally detrimental to health; increased PUFA consumption is not necessarily 
healthy; and MUFAs are mostly neutral.  Fats that have a high MUFA content are 
seen as a healthier choice than a fat with a high SFA or PUFA content.  This is 
also why oils like rape seed-, canola- and olive oil are considered as such 
healthy oils (Ong and Goh, 2002).  The high MUFA:SFA ratio implies that lipid 
levels will stay unchanged, and this is favourable when consuming a fat.   
Questions can be raised about the high content of saturated fatty acids in 
RPO and the implication of this on cardiovascular health.  However, RPO has 
certain attributes that potentially place it in a category of a healthy oil.  One of 
these attributes is that the fatty acids in the sn-2 position of RPO are 
predominantly unsaturated (87%), whilst the sn-1 and sn-3 positional fatty acids 
are more highly saturated.   
All oils and fats have one of three triacylglicerol or triglyceride structures.  
The differences between fats lie in the types of fatty acids (ROOH) that are 
attached to the glycerol backbone in position sn-1, sn-2, and sn-3.  The position 
of attachment (sn-1, 2, or 3) to the glycerol backbone plays a role in determining 
the preferential absorption and subsequently the levels of blood triacylglycerols 
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and cholesterol (Ong & Goh, 2002).  Studies have shown that the sn-2 positional 
fatty acids are mostly absorbed.  This is due to specific actions of pancreatic 
lipase enzymes (Mattson & Volpenhein, 1959; Small, 1991; Kritchevsky et al., 
1996; Goh, 1999; Willis et al., 1998; Kritchevsky et al., 1998; Kritchevsky et al., 
1999).  The sn-1 and sn-3 positional fatty acids are less readily absorbed, 
especially if they are long-chain saturated fatty acids (Kritchevsky et al, 1995; 
Willis et al, 1998; Kritchevsky et al, 1998; Goh, 1999). 
RPO’s SFAs (palmitic- and stearic acid) are mostly situated in postions sn-1 
and sn-3, whilst the UFAs (oleic and linoleic acid) is mostly situated in position 
sn-2 (USADA, 1979; Small, 1991; Gunstone et al., 1994; Gunstone, 1996; Willis 
et al., 1998; Siew, 2000).  This implies that the unsaturated fatty acids of RPO 
will be more readily absorbed than the saturated fatty acids.  Thus, the relatively 
high content of saturated free fatty acids in the digested RPO, when compared to 
other fats and oils, will be less easily absorbed.  Most of the sn-1 and sn-3 
position unsaturated fatty acids are absorbed while the saturated fatty acids from 
these positions are excreted as salts.  Only a minimal amount of saturated fatty 
acids from the sn-2 position will be absorbed.   
As a result, none of the fatty acids in RPO, whether saturated (palmitic & 
stearic) or unsaturated (oleic & linoleic) has cholesterol elevating effects.  RPO 
behaves like a monounsaturated oil, because most of the fatty acids that are 
absorbed are UFAs, even though it is classified as a saturated oil (Mattson & 
Volpenhein, 1959; Kritchevsky, 1995; Kritchevsky et al, 1999; Ong & Goh, 2002). 
Coconut oil and many animal fats have large amounts of saturation on the sn-2 
positional fatty acids and this account for the hypercholesterolaemic properties in 
these fats (Ong & Goh, 2002).   
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2.7.2 Carotenoids 
Carotenoids are a group of red, orange and yellow pigments found in 
plants, especially in fruit and vegetables, but are not synthesized by animals 
(Stahl and Sies, 2003).  Red Palm oil is a well known source of carotenoids.   
Of the carotenes present in RPO, only -, -, and -carotenes have 
provitamin A activity.  The main component of these carotenoids is -carotene, 
which is a precursor of vitamin A (table 2) (Choo et al., 1992; Choo, 1995; 
Scrimshaw, 2000).   
Table 3 shows a comparison of the vitamin E and carotene content between 
Carotino palm oil and other plant oils.  In comparison to other oils, red palm oil is 
naturally much richer in carotenoids.  It is 15 times richer in carotenes compared 
to carrots and contains 50 times more carotenes than tomatoes (Kamen, 2000).  
 
Table 2-3:  Comparison between Carotino palm oil and other plant oils 
 
Carotino 
Premium 
(Red Palm 
oil) 
Carotino 
classic (Red 
Palm oil) 
Sunflower 
seed oil 
Safflower 
seed oil 
Corn oil Olive oil 
Vitamin E 
mg/kg 
80 50 39 17,4 20.7 7.6 
Carotene 
mg/kg 
50 12.5 0 0 0 0 
(Reproduced from Kamen, 2000) 
-Carotene is an effective antioxidant because it is one of the most powerful 
singlet oxygen quenchers.  It can disperse the energy of a singlet oxygen, thus 
preventing this active molecule from generating free radicals (Bagchi & Puri, 
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1998).  It thus protects cells and tissue from oxidative damage.  This protection is 
only seen at low partial oxygen pressure, as found in the body.  When the partial 
pressure of oxygen is increased, -carotene looses its antioxidant activity and 
exhibited a pro-oxidant effect (Palozza et al., 1995).  This illustrates the 
importance of oxygen tension on the antioxidant/pro-oxidant effects of -
carotene.   
In certain animal models, carotenoid compounds can act as antioxidants, 
cancer-preventative agents and anti-atherosclerotic agents.  However, animal 
models cannot be directly correlated to humans, because most laboratory 
animals absorb carotenoids differently to humans (Pavia and Russell, 1999).  
Observational studies showed an inverse relationship between various cancers 
and carotenoid intake, especially with cardiovascular disease.  However, other 
studies showed no protective effects against cancer or cardiovascular disease 
when the diet was supplemented with high doses of -carotene (Pavia and 
Russell, 1999).  However, this was an extracted form of -carotene, and not its 
natural form.  It is also possible that the combination of carotenes and other 
antioxidants exert a better effect when they are supplemented individually.   
There is also conflicting evidence about the effect of β-carotene on LDL 
oxidation.  High doses of -carotene supplementation resulted in an increased 
susceptibility of LDL to oxidation (Gaziano et al., 1995).  However, Lin et al., 
(1998) showed that a depletion of -carotene also lead to an increased 
susceptibility of LDL to oxidation.  The only protection can be seen when a 
normal intake of -carotene was provided.   
Scientific evidence indicates that carotenes are healthy when taken at 
physiological levels, but when they are taken in high dosages or in the presence 
of highly oxidative conditions, their effects maybe adverse.  It is also possible that 
mixtures of carotenoids with other antioxidants, as in RPO, can increase the 
ability of the antioxidant to offer protection against lipid peroxidation.  Implying 
that when carotene is extracted from its natural environment, it has different 
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effects than when it is in its natural environment.  Even though carotenoids are 
not essential for human health, they have biological actions that may be 
important in maintaining health and preventing the appearance of serious 
diseases.   
Lycopene is also a carotenoid antioxidant.  Among the many natural 
carotenoids, lycopene is recognized to be the most potent singlet oxygen 
quencher and free radical scavenger (Di Mascio et al., 1989).  The radical 
quenching activity of lycopene is twice that of β-carotene and ten times that of β-
tocopherol (Böhm et al., 2001; Woodall et al., 1995; Di Mascio et al., 1989). 
In contrast to β-carotene, lycopene is not a precursor of vitamin A in 
humans.  Besides its antioxidant effect, it influences the expression of various 
proteins (Banhegyi, 2005).  Epidemiological and animal studies have provided 
convincing evidence that supports the role of lycopene in the prevention of 
chronic deseases (Rao et al., 2006; Shao & Hathcock, 2006).   
Dietary consumption and serum levels of lycopene have been linked to a 
reduced risk of cardiovascular disease (Arab & Steck, 2000; Willcox et al., 2003) 
as well as prostate cancer (Chan et al., 2005; Giovannucci, 2005).  Placebo-
controlled intervention trials showed that the consumption of lycopene can 
reduce DNA damage (Astley et al., 2004; Zhao et al., 2006) and lung cancer (Liu 
et al., 2003, 2006; Wang, 2005). Matulka et al., (2004) found no indication of 
adverse effects with natural sources of lycopene.  
Lycopene has been reported to decrease the infarct size in 
ischaemia/reperfusion brain injury (Hsiao et al., 2004).  Some studies have 
reported that diets rich in lycopene lower cholesterol and lipid peroxidation (De 
Lorgeril et al., 1999; Rissanen et al., 2001).  However, it was more recently found 
that lycopene does not affect plasma lipids or antioxidant status of healthy 
subjects (Collins et al., 2004).  
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It has also been found that lycopene is able to reduce the risk of 
atherosclerosis and cardiovascular disease by decreasing the susceptibility of 
LDL to oxidative modification (Hadley et al., 2003; Kohlmeier et al., 1997). 
 
2.7.3 Vitamin E (tocopherols and tocotrienols) 
Palm oil is a rich source of vitamin E and vitamin E associated compounds.  
Vitamin E is the collective name for eight compounds, four of which are 
tocopherols and the other four are tocotrienols (Bagchi & Puri, 1998).   All 
vegetable oils have tocopherols, but palm oil also has an abundance of 
tocotrienols.  An important attribute of palm oil is the fact that among vegetable 
oils, it is the only rich source of tocotrienols (Kamen, 2000).  
Vitamin E has antioxidant properties, especially against lipid peroxidation in 
biological membranes (Theriault et al., 1999).  Tocopherols and tocotrienols are 
known natural antioxidants (Goh et al., 1990; Ong & Packer, 1992; Baskin & 
Salem, 1997; Ong & Packer, 1998; Goh et al., 1998) that protect the oil from 
oxidation.  
Vitamin E has a high lipophilic activity and is the major lipid-soluble chain-
breaking antioxidant found in blood plasma.  It also protects polyunsaturated fatty 
acids in cell membranes from peroxidation by retarding oxidation (Bagchi & Puri, 
1998).  The oxidation of PUFAs leads to disturbances in membrane structure and 
function.  Vitamin E protects against these damaging effects of oxidation by 
preventing the auto-oxidation of these lipids (Burton & Ingold, 1981).  Vitamin E 
is a singlet oxygen quencher and neutralises these highly reactive and unstable 
molecules (Kamal-Eldin & Appelqvist, 1996).   
Serbinova and co-workers (1992) were the first to show that palm oil vitamin 
E (containing both -tocopherol and -tocotrienol) improved reperfusion 
functional recovery in a Langendorff-perfused rat heart.  The protection was 
attributed to the ability of both tocopherols and tocotrienols to scavenge free 
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radicals during reperfusion.  Thereafter, Bagchi & Puri (1998) also showed that 
vitamin E protected against ischaemia and reperfusion injury.  Venditti and co-
workers (1999) also reported protection against ischaemia/ reperfusion-induced 
oxidative stress with vitamin E treatment.   
It can be speculated that tocopherols and tocotrienols capture and destroy 
damaging free oxygen radicals that have been implicated in cellular aging, 
atherosclerosis and cancer (Kok et al., 1987; Salonen et al., 1988; Teoh et al., 
1992; Tomeo et al., 1995).  Laboratory experiments performed on isolated rat 
hearts have shown that a tocopherol/tocotrienol concentrate from palm oil is 
more efficient than -tocopherol alone in protecting the heart against the 
oxidative injury usually associated with reperfusion (Esterbauer et al., 1989; 
Steinberg et al., 1989; Serbinova et al., 1991; Serbinova et al., 1992).  This 
abovementioned concentrate, was also used in an experiment to treat patients 
with vascular disorders that cause a limitation in blood flow.  The subjects that 
received the concentrate showed a significant increase in walking distance 
before onset of pain, in comparison with the groups given aspirin or a placebo.  
The oxidation in their blood lipids was also significantly reduced.  These natural 
antioxidants protect LDLs (which are involved in the formation of atheriosclerotic 
lesions) from oxidation.  
In a cross-cultural epidemiological study done by Gey et al, (1991) the 
amount of vitamin E in the plasma showed a strong inverse correlation with age-
specific mortality from coronary heart disease.  It was also found that there was 
protection against protein oxidation induced during resting as well as exercise, 
when supplemented with tocopherol and tocotrienols (Reznick et al., 1992).   
Tocopherol is considered the most active form of vitamin E, but tocotrienol 
the most potent antioxidant (Goh et al., 1990; Serbinova et al., 1991; Suzuki et 
al., 1993; Goh et al., 1998). Tocotrienols have been shown to be an effective 
inhibitor of breast and liver cancer cell growth (Sundram et al., 1989; Goh et al., 
1990; Goh et al., 1994; Nesaretnam et al., 1995).  It can also prevent oxidation of 
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protein and lipids after strenuous bouts of exercise.  Differing from -tocopherol, 
tocotrienols are not accumulated in the liver and seem to benefit the epidermis of 
the skin (Hew et al., 1994; Traver et al., 1998). 
The more potent antioxidant activity of tocotrienols has been attributed to a 
number of mechanisms which include efficient interaction with free radical 
species, higher recycling efficiency of the chromanoxyl radical and uniform 
distribution of tocotrienols in membrane bilayers (Serbinova et al., 1991; Theriault 
et al., 1999). 
It was concluded from studies done by Yoshidu (2003) and Sen (2000) who 
compared the antioxidants activities of tocopherols and tocotrienols, that 
tocotrienols were more effective due to the fact that they are 
absorbed/incorporated more effectively. 
Non-antioxidant functions of vitamin E have been proposed, especially that 
of a “gene regulator”.  These effects of vitamin E have been observed at the level 
of mRNA or protein and can be due to regulation of gene transcription, mRNA 
stability, protein translation, protein stability and post-translational events 
(Ricciarelli et al., 2001; Azzi et al., 2002).   
Tocotrienols also possess cholesterol lowering effects together with the 
ability to reduce the atherogenic apolipoprotein B and lipoprotein (Aa serum 
levels (Hood, 1995).  It has also been suggested that tocotrienols have anti-
thrombotic and anti-tumourigenic effects.  This indicates that tocotrienol may 
serve as an effective agent in the prevention and/or treatment of cardiovascular 
disease and cancer (Guthrie et al., 1995; Qureshi et al., 1997).  Animal studies 
have shown that tocotrienols inhibit the enzyme HMG-CoA reductase and thus 
the synthesis of cholesterol (Parker et al., 1993; Khor et al., 1995).  Tocotrienols 
can reduce the aggregation of blood platelets, and thus reducing the tendency for 
blood clot formation (Ong and Goh, 2002).   
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Hornstra (1988) showed that palm oil (containing tocopherols and 
tocotrienols) has anti-clotting effects, and the same antithrombotic effect as the 
highly unsaturated sunflower seed oil. Scientific evidence suggests that a palm 
oil containing diet either increases the production of prostacyclin (inhibits blood-
clotting) or decreases formation of thromboxane (induces blood-clotting).  These 
findings indicate that palm oil potentially has the same antithrombotic effect as 
polyunsaturated oils (Rand et al., 1988; Abeywardena et al., 1987; Abeywardena 
et al., 1997).   
Epidemiological studies also showed that high vitamin E intake is 
associated with a reduced risk of coronary heart disease.  Vitamin E treatment 
significantly reduced the risk of cardiovascular deaths as well as non-fatal 
myocardial infarctions (Stephens et al., 1996).  Tocopherol and tocotrienol 
inhibits human platelets from coagulation, this in itself prevents thrombosis.  In 
conjunction with this, tocotrienol supplementation, derived from palm oil, can 
reduce restenosis of patients with carotid atherosclerosis (Tomeo et al., 1995; 
Kooyenga et al., 1996).   
2.7.4 Ubiquinones 
Crude palm oil and RPO contains small amounts of ubiquinones.  Of these, 
coenzyme Q10 (CoQ10) is the most common.  CoQ10 has been reported to be 
beneficially involved in several mechanisms:  It can boost the immune system, 
relieve angina, afford protection against heart disease and reduce blood pressure 
at relatively low concentrations of CoQ10 intake (Nagendran et al., 2000).  
It is also known for its role in the mitochondrial electron-transport system 
and it also has antioxidant properties in the ischaemic/reperfused myocardium in 
rats (Hano et al., 1994).  CoQ10 might be a free radical scavenger and may 
preserve coronary vessel mechanical function during ischaemia or reperfusion 
through a direct antioxidant mechanism (Yokoyama et al., 1996).  
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CoQ10 may also have a protective effect against breast cancer (Portakal et 
al., 2000), and may even be used as a treatment for breast cancer (Lockwood et 
al., 1994; Lockwood et al., 1995).  It is also protective against heart damage 
related to chemotherapy (Folkers, 1996). 
 
2.8 The beneficial effects of RPO: a review of the 
evidence 
2.8.1   Cancer and Vitamin A deficiency 
It is well documented that a high dietary fat intake increases the risk of 
colon cancer (Slattery et al., 1997; Dwivedi et al., 2003; Nkondjock et al., 2003).  
However, it has been proposed that dietary fat, depending on the source, 
quantity and fatty acid composition (saturated, monounsaturated or 
polyunsaturated) can reduce the incidence of colon cancer (Dwivedi et al., 2003; 
Nkondjock et al., 2003).   
Nakayama et al. (1993) observed an increase in tumour size in rats that 
were fed a corn oil diet, but no increase was seen in those fed palm oil.  Red 
palm oil and its bioactive components are, based on recent scientific evidence, 
displaying increased protection against many cancers (Manorama et al., 1993; 
Yu et al., 1999; Boateng et al., 2006).   
It was also found that RPO in the maternal diet improved the vitamin A 
status of lactating mothers and their infants (Lietz et al., 2000).  In another study, 
children were supplemented with RPO and/or retinol.  The increase in serum 
retinol levels was similar in both groups after 2 months of supplementation 
(Manorama, et al., 1996).  Aykroyd & Wright (1937) gave vitamin A-deficient 
rabbits crude RPO and found that the oil cured the characteristic eye lesions of 
vitamin A deficiency in animals.  This was followed with clinical trials that showed 
that RPO was an effective substitute for cod liver oil in the treatment of 
keratomalacia (Vitamin A deficiency).   
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Investigations performed in India have established that 5 to 8g of RPO 
given daily to children as a supplementary food can improve their vitamin A 
status within about six months (Manorama et al. 1996; Mahapatra et al., 1997).  
 
2.8.2  RPO and its effect on serum cholesterol 
Palm oil is also beneficial as it does not promote the formation of plaques in 
the arteries.  When high-cholesterol diets along with certain saturated fats (milk 
fat, tallow, and coconut oil) are fed to rabbits, quails, pigs and monkeys, 
atherolsclerosis can be induced.  Honstra et al, (1987) tested the effects of palm 
oil on atherosclerosis.  It was found that after 18 months of feeding, the rabbits 
that received palm oil and sunflower oil diets, had the lowest degree of 
atherosclerosis in comparison with fish oil, linseed oil, and olive oil.  In a 
subsequent study by Honstra (1988), it was found that palm oil showed no 
difference in a number of atherosclerosis lesions when compared to cottonseed 
oil, hydrogenated cottonseed oil and an experimental fat blend.  These oils were 
all found to be anti-atherosclerotic.  Kritchevsky et al., (1999) also showed that 
RPO reduces atherosclerosis in rabbits.   
A desirable serum lipid profile is one that has low plasma total cholesterol 
(TC), triglycerides (TG) and low-density lipoprotein cholesterol (LDL-C) levels 
and high high-density lipoprotein cholesterol (HDL-C) levels (Matton & Grundy, 
1985).   
Human feeding studies performed before 1990, showed that palm oil diets 
resulted in a reduction in blood cholesterol values (Ahrens et al., 1957; Keys et 
al., 1965; Baudet et al., 1984; Mattson & Grundy, 1985; Bonanome & Grundy, 
1988).   
Recent nutritional studies confirmed that the effects of palm oil on blood 
cholesterol and lipoprotein profiles are beneficial.  These studies showed that 
palm olein (the liquid fraction of palm oil) had similar effects as olive oil on 
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lowering cholesterol levels (Ng et al., 1992; Choudhury et al., 1995). This was 
also shown by another study that indicated that a palm oil supplemented diet had 
the same effects as an oleic acid supplemented diet (oleic acid is the main fatty 
acid in olive oil) (Sundram, 1997).  Palm oil induced an increase in the “good” 
HDL-cholesterol and a decrease in the “bad” LDL- cholesterol as well as the total 
blood cholesterol (Ng et al., 1991; Truswell et al., 1992; Farooq et al., 1996; 
Zhang et al., 1997; Chandrasekharan, 1999; Theriault et al., 1999; Kritchevsky, 
2000).  Palm olein also did not raise cholesterol (Ghafoorunissa et al., 1995). 
The above evidence indicates that the effect of palm oil on blood lipid levels 
more closely resembles that of a monounsaturated oil rather than a saturated oil.  
These studies suggest that palm oil does not raise serum TC or LDL cholesterol 
levels to the extent expected from a fat that has such a high saturated fatty acid 
content.   
2.8.3   RPO and ischaemia/reperfusion injury 
During myocardial reperfusion, there is an increase in free oxygen radicals 
due to the sudden oxygen burst induced by reoxygenation of the heart.  These 
radicals include: superoxide radical (O2-), hydrogen peroxide (H2O2) and hydroxyl 
radical (OH), which are implicated in the pathogenesis of ischaemia/reperfusion 
injury.  They interact with nucleic acids, proteins and lipids and thus cause 
damage to cell membranes or intracellular organelles (Serbinova et al., 1992; 
Wall, 2000; Illarion et al., 2002).  
In a recent study by Esterhuyse et al. (2005), it was found that a RPO-
supplemented diet caused an improved functional recovery during reperfusion in 
the working heart model.  This recovery was associated with increased levels of 
cGMP and decreased levels of cAMP in the heart.  The increased cGMP levels 
possibly protected the myocardium by decreasing reperfusion induced cytosolic 
Ca2+ overload.  An increase in cAMP activity would increase Ca2+ and 
aggrevates ischaemia/reperfusion injury (Du Toit et al., 2001).  Thus, it seems 
that cGMP may be an endogenous intracellular cardioprotectant (Pabla et al., 
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1995).  An increase in functional recovery was also seen in a RPO-supplemented 
high fat diet group.  This improvement could not be linked to changes in NO-
cGMP pathway activity (Esterhuyse et al., 2005).  There must be another 
pathway that activates the beneficial effects of RPO in a high fat diet.  It is 
proposed that both the antioxidants as well as the fatty acids play a role in the 
protection induced by RPO under these conditions. 
RPO also protected against ischaemai/reperfusion injury in diets that are 
rich in SFAs and PUFAs.  Together these results indicate that RPO was effective 
to protect against ischaemia/reperfusion in a normal rat chow diet (Esterhuyse et 
al., 2005; Engelbrecht et al., 2006), a high cholesterol diet (Esterhuyse et al., 
2006; Kruger et al., 2007), an oxidative risk induced diet and a high fat diet 
(Bester et al., 2006).  
In other studies performed on RPO it was found that RPO-supplementation 
showed a significant increase in PKB/Akt phosphorylation (Engelbrecht et al., 
2005) and a significant inhibition of pro-apoptotic proteins (Kruger et al.,2007) 
during reperfusion.  These changes were also associated with increased 
mechanical functional recovery of the heart.  This indicated that the improved 
physiological function associated with RPO-supplementation (Esterhuyse et al., 
2005) was due to cellular signalling effects of RPO.   
Although lipids have been an essential component of human diets, it seems 
that an important basic level of control of cardiac function by a simple dietary 
choice of RPO has been largely overlooked. Much work, especially carefully 
planned basic research to further explore the mechanisms as well as clinical 
trials are needed to test whether this natural oil will fulfil the need of a safe and 
effective therapeutic agent. 
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Chapter 3 MATERIAL AND METHODS 
3.1 Animal Care 
The animals used in this study were male, Wistar rats.  All animals used in 
the study received humane care in accordance with the Principle of Laboratory 
Animal Care of the National Society of Medical Research and the Guide for the 
Care and use of Laboratory Animals of the National Academy of Sciences.  
(National Institutes of Health Publications no. 80-23, revised 1978).  Rats had ad 
lib access to food and water.  They were housed in an animal house at a 
constant temperature of 27oC and were exposed to a twelve-hour artificial day-
night cycle. 
3.2 Experimental Model 
3.2.1 Experimental Groups 
Male Wistar rats were divided into four groups:  two control groups receiving 
standard rat chow and two experimental groups receiving standard rat chow plus 
2ml RPO for 4 weeks.  Carotino Premium, supplied by Carotino, Malaysia, was 
used for the experimental group.  The reason for using 2 ml RPO was that in 
previous studies (Esterhuyse et al., 2005), 0.2 ml of a baking fat form of RPO 
was used.  The Carotino Premium that we used was much less concentrated 
than the baking fat.  Therefore, an increased dosage was used.  The energy and 
macronutrient content of the two diets are shown in Table 3-1. 
3.2.2 Heart perfusion 
At the end of the feeding programme, rats weighing 300-400g were 
anaesthetized with an intraperitoneal injection of 2mg/kg intraval sodium (sodium 
pentobarbital), before the hearts were rapidly excised and placed in ice-cold 
Krebs-Henseleit buffer.  Hearts were transferred to the Langendorff perfusion 
apparatus and perfused with a Krebs-Henseleit buffer equilibrated with 95% O2 
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and 5% CO2 at 37oC (118,5 mM NaCl;  4,75 mM KCl;  1,2 mM MgCl 6 H2O ;  
1,36 mM CaCl2;  25,0 mM NaHCO3; 1,2 mM KH2PO4;  11,0 mM glucose).  
Pressure was kept constant at 100 cm H2O with a flow pump.    
 
Table 3-1:  The energy and macronutrient content of the two diets 
used in this study 
Nutrient Standard rat 
chow  * 
RPO 2 ml 
 
Standard rat 
chow+RPO** 
Energy (kJ) 272,5 68 340.5 
Total non 
structural 
carbohydrates (g) 
8,375 0 8,375 
Total Protein (g) 4,5 0 4,5 
Total Fat (g) 0,625 1.84 2.465 
Total SFA (g) 0,139 0.74 0.879 
Total MUFA (g) 0,168 0.86 1.028 
Total PUFA (g) 0,297 0.24 0.537 
*25 g of standard rat chow per day 
**25 g of standard rat chow plus 2ml red palm oil per day 
SFA = saturated fatty acids 
MUFA = monounsaturated fatty acids 
PUFA = polyunsaturated fatty acids 
 
 
The aorta was cannulated and retrograde perfusion with Krebs-Henseleit 
buffer was initiated.  Immediately after cannulation, excess tissue was removed 
from the heart and the left atrium was removed.  A thermomix waterbath was 
used to keep the Langendorff perfusion system’s temperature constant 
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throughout the experiment by circulating warm water through the water-jacketed 
glass reservoir.  The temperature was monitered at regular intervals to ensure 
that the temperature was maintained at 37oC irrespective of coronary flow.  A 
balloon, made from transparent sandwich wrap film and filled with water, was 
inserted into the left ventricle through the opening of the left atrium.  The balloon 
is connected to a Powerlab system (ADInstruments Pty Ltd. Castle Hill, Australia) 
on a computer.  After insertion, the balloon is inflated to 2 mmHg, and the 
contraction force of the heart against the balloon causes water displacement that 
is converted to pressure.  Through this the systolic and diastolic pressures as 
well as the heart rate were read on the computer.  The first 10 min of perfusion 
was used to stabilize the heart. 
3.2.3 Exclusion criteria: 
Rats with body mass outside of the range of 300-400 g were not used for 
experiments.  Hearts with a heart rate above 350 or below 210 beats per min and 
LVDevP above 150 or below 70 mmHg during the stabilization phase were also 
excluded from the experiment.   
 
3.3 Perfusion protocol 
The study was divided into two perfusion protocols (Figure 3-1).  In the first 
protocol, hearts were perfused with Krebs-Henseleit buffer for 10 min 
stabilization, followed by 20 min, during which mechanical function was 
documented.  Hearts were then subjected to 25 min of total global ischaemia.  
After the ischaemic period, hearts were reperfused for 30 min, and mechanical 
function was again documented. In order to reduce the incidence of reperfusion 
arrhythmias, 2% lignocaine solution was used for the last min of pre-ischaemia 
perfusion as well as the initial 3 min of reperfusion of all hearts.   
Functional and biochemical measurements were taken.  Mechanical 
functional parameters measured during pre-ischaemia and during reperfusion at 
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timepoints 5 min, 10 min, 15 min and 25 min.  Biochemical measurements were 
only done at 10 min reperfusion.   
In the second protocol, hearts were stabilized for 10 min and perfused for 
15 min with normal Krebs-Henseleit buffer, before being subjected to a 
wortmannin solution (100 nM) for 5 min pre-ischaemia.  After the 25 min total 
global ischaemia period, hearts were reperfused for 3 min with the wortmannin 
solution, before reverting to the drug-free Krebs-Henseleit buffer for the rest of 
the 27 min reperfusion period.  A set of functional and biochemical measurement 
were again taken.   
3.4 Mechanical function parameters measured: 
Functional measurements were taken during pre-ischaemia (20 min 
perfusion) and at 5 min, 10 min, 15 min and 25 min into reperfusion.  All the 
results are given as reperfusion mechanical function percentage recovery.  This 
was determined by dividing the value obtained during reperfusion by the pre-
ischaemic value and multiplying it by 100.  
3.4.1 Coronary flow (ml/min) 
The coronary flow was measured by collecting the coronary effluent from 
each sampling point for 1min, in a measuring cylinder.   
3.4.2 Heart rate (bpm) 
The heart rate was determined by the Powerlab system that was connected 
to the balloon that was inserted into the left ventricle of the heart. 
3.4.3 Left Ventricular developed pressure (LVDevP) (mmHg) 
Left ventricular systolic (LVSP) and diastolic (LVDP) pressure were 
measured by the Powerlab system by means of the generation of pressure on 
the balloon inserted into the left verntricle of the heart.  LVDevP (the difference 
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between systolic and diastolic pressure) was calculated and used as a measure 
of mechanical function of the heart.    
 
 
 
 
 
 
 
# Groups received SRC or SRC + RPO 
Functional measurements (LVDevP, HR and CF) 
SRC = Standard rat chow; RPO = Red palm oil; LVDevP = Left ventricular 
developed pressure; HR = Heart rate; CF = Coronary flow 
Figure 3-1:  Study design 
 
3.4.4 Rate Pressure Product (RPP) 
RPP was also used to assess mechanical function of the heart.  RPP was 
determined using the following formula: 
RPP = heart rate (HR) x LVDevP 
 
No flow 
ischaemia 
Reperfusion Perfusion 
4 weeks 
supplementation 
period # 
Time (min)                             0                  20                                                     45              60               80 
Functional measurements                         20                                                          50   55   60     70 
Biochemical measurements                                                                                           55 
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3.5 Biochemical analysis 
To assess myocardial biochemical function, hearts, from all the groups, 
were freeze clamped 10 min into reperfusion with Wollenberger clamps 
precooled in liquid nitrogen.  Samples were then stored at -80oC until analysis 
were performed.    
 Cardiac PKB/Akt, caspase and poly-ADP-ribose-polymerase (PARP) 
protein  were extracted with a lysis buffer containing (in mM):  Tris 20, p-
nitrophenylphosphate 20, EGTA 1, NaF 50, sodium orthovanadate 0.1, 
phenylmethyl sulfonyl fluoride (PMSF) 1m dithiothreitol (DTT) 1, aprotinin 10 
g/ml.  The tissue lysates were diluted in Laemmli sample buffer, boiled for 5 min 
and 60 g protein were separated by 10% PAGE-SDS gel electrophoresis 
(Caspase was 15%).  The lysate protein content was determined using the 
Bradford technique (Bradford, 1976).  The separated proteins were transferred to 
a PVDF membrane (Immobilon P, Millipore).  These membranes were routinely 
stained with Ponceau Red for visualization of proteins.  Nonspecific binding sites 
on the membranes were blocked with 5% fat-free milk in Tris-buffered saline – 
0.1% Tween 20 (TBST) and then incubated with the primary antibodies that 
recognize PKB/Akt (Ser473 and Thr308) and total PKB/Akt, PI3-K (p85), PDK1 
(Ser241), FKHR (Ser256), GSK-3β (Ser9), cleaved caspase-3 (Asp175), cleaved 
PARP (Asp214) and PTEN (Ser380).  Membranes were subsequently washed with 
large volumes of TBST (5x5 minutes) and the immobilized antibody conjugated 
with a diluted horseradish peroxidase-labeled secondary antibody (Amersham, 
LIFE SCIENCE).  After thorough washing with TBST, membranes were covered 
with ECL detection reagents and quickly exposed to an autoradiography film 
(Hyperfilm ECL, RPN 2103) to detect light emission through a non-radioactive 
method (ECL Western blotting).  Films were densitometrically analyzed (UN-
SCAN-IT, Silkscience) and phosphorylated protein values were corrected for 
minor differences in protein loading, if required. 
Antibodies were purchased from Cell Signalling Technology and all other 
chemicals were obtained from Sigma (St Louis, MO). 
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3.6 Statistics 
Values are expressed as mean  standard error of the mean (SEM).  Some 
functional values are presented as percentage change from the baseline values.  
Results were compared by using a one-way ANOVA with a Bonferoni Multiple 
Comparison as a post hoc test.  P0.05 was considered as statistically 
significant.  
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Chapter 4 RESULTS 
4.1 Mechanical Function data 
4.1.1 Coronary flow recovery (%)  
The coronary flow recoveries in all groups were similar with no significant 
differences (Figure 4-1).  
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Figure 4-1: The effect of RPO-supplementation and Wortmannin 
administration on CF recovery during reperfusion (mean  SEM) 
CF = Coronary Flow; C = Control; RPO = Red Palm Oil; Wn = Wortmannin
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4.1.2 Heart rate recovery (%)  
The percentage heart rate recovery after ischaemia is shown in Figure 4-2.  
No differences between the groups were observed.  
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Figure 4-2:  The effect of RPO-supplementation and Wortmannin 
administration on HR recovery during reperfusion (n=4-7 per group) (mean 
+/- SEM) 
HR = Heart rate; C = Control; RPO = Red Palm Oil; Wn = Wortmannin
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4.1.3 Left Ventricular developed pressure (LVDevP) recovery 
(%) 
Our results show significant differences between groups in the percentage 
LVDevP recovery (Figure 4-3).  After 5 min reperfusion, the RPO+Wn group had 
an increased % LVDevP recovery vs the control+Wn group (186.98  5.21 % vs  
81.55  9.00 %; p0.01).  The RPO+Wn group also showed an increased 
LVDevP recovery after 15 min vs the RPO group (151.45  12.02 % vs 107.45  
6.14 %; p0.05). This implies that the RPO+Wn combination increased 
contractile functional recovery.   
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Figure 4-3:  Percentage LVDevP recovery seen with RPO-
supplementation and Wortmannin administration during reperfusion (n=4-8 
per group) (mean +/-SEM) (*p0.05 and # p 0.01 for indicated groups). 
LVDevP = Left Ventricular Developed Pressure; C = Control; RPO = Red Palm Oil; Wn = 
Wortmannin 
#
*
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4.1.4 Rate Pressure Product recovery (%) 
RPO-supplementation caused an increase in % RPP recovery at 10 min 
during reperfusion when compared with the control group (63.86 ± 7.74 % in 
control vs 92.26 ± 5.89 % in RPO; p0.05) confirming results in previous similar 
studies (Figure 4-4).  Secondly, RPO+Wn also improved % RPP at timepoints 5 
& 15 min (110.07 ± 7.00 % & 151.21 ± 36.67 %; p0.01) vs control+Wn (42.52 ± 
8.10 % & 81.69 ± 7.65 %; p0.05).  Our results also show that RPO+Wn 
improved % RPP at 5 min when compared with RPO alone (110.07 ± 7.00 % vs 
43.07 ± 5.76 %; p0.01).   
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Figure 4-4:  The effect of RPO-supplementation and Wortmannin 
administration on RPP recovery during reperfusion (n=4-8 per group) 
(mean +/- SEM), (* p<0.05 and # p<0.01 for indicated groups) 
RPP = Rate Pressure Product; C = Control; RPO = Red Palm Oil; Wn = Wortmannin 
*
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*
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Biochemical data 
4.1.5 PI3-Kinase (p85) 
The PI3-kinase (p85) activity is shown in Figure 4-5.  RPO+Wn significantly 
decreased PI3-K (p85) activity compared to RPO alone (37.9 ± 3.3 pixels vs 54.5 
± 1.0 pixels; p0.001).   
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Figure 4-5: The effect of RPO-supplementation and Wortmannin 
administration on PI3-K (p85) activity in hearts subjected to 
ischaemia/reperfusion (n=3-7 per group) (mean +/- SEM), ($ p<0.001 for 
indicated groups)   
C = Control; RPO = Red Palm Oil; Wn = Wortmannin 
$
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4.1.6 PTEN (Ser380)  
PTEN activity (Figure 4-6) was increased in the control+Wn group when 
compared to the control group (72.4 ± 2.7 pixels vs 52.3 ± 2.8 pixels; p0.01).  
Wortmannin administration during perfusion showed a decreased PTEN activity  
for the RPO+Wn group when compared with the control+Wn group (41.2 ± 3.5 
pixels vs 72.4 ± 2.7 pixels; p0.001). Wn increased the phosphorylation of PTEN, 
an effect which was prevented by RPO.  
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Figure 4-6: The PTEN (Ser) activity after RPO-supplementation and 
Wortmannin administration in hearts subjected to ischaemia/reperfusion 
(n=3-7 per group) (mean ± SEM) (# p<0.01 and $ p<0.001 for indicated 
groups) 
C = Control; RPO = Red Palm Oil; Wn = Wortmannin
$#
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4.1.7 PDK (Ser241) 
PDK phosphorylation in all four groups were similar after 10 min of 
reperfusion (Figure 4-7). 
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Figure 4-7:  The effect of RPO-supplementation and Wortmannin 
administration on PDK activity in hearts subjected to 
ischaemia/reperfusion (n=3-7 per group) 
C = Control; RPO = Red Palm Oil; Wn = Wortmannin 
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4.1.8 PKB/Akt (Ser473) 
Wortmannin administration during perfusion decreased PKB/Akt (Ser473) 
phosphorylation in the control group (33.2 ± 10.7 pixels vs 106.4 ± 7.8 pixels; 
p0.01).  This decrease in phosphorylation was reversed with the addition of 
RPO to wortmannin (33.2 ± 10.7 pixels vs 75.87 ± 10.3 pixels; p0.05) (Figure 4-
8).  
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Figure 4-8: The effect of RPO-supplementation and Wortmannin 
administration on PKB/Akt (Ser473) phosphorylation in hearts subjected to 
ischaemia/reperfusion (n=3-7 per group) (mean ± SEM) (* p<0.05 and # 
p<0.01 for indicated groups)  
C = Control; RPO = Red Palm Oil; Wn = Wortmannin
*
#
Stellenbosch University  http://scholar.sun.ac.za 
  51
4.1.9 PKB/Akt (Thr308) 
No differences in phosphorylation between groups were found in PKB/Akt 
(Thr308) (Figure 4-9). 
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Figure 4-9: The effect of RPO-supplementation and Wortmannin 
administration on PKB/Akt (Thr308) phosphorylation in hearts subjected to 
ischaemia/reperfusion (n=3-7 per group) (mean ± SEM) 
C = Control; RPO = Red Palm Oil; Wn = Wortmannin 
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4.1.10 PKB/Akt (Tot)  
The PKB/Akt (Tot) activity is given in Figure 4-10, no differences were found 
between the groups. 
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Figure 4-10: The effect of RPO-supplementation and Wortmannin 
administration on the total PKB/Akt activity in hearts subjected to 
ischaemia/reperfusion (n=3-7 per group) 
C = Control; RPO = Red Palm Oil; Wn = Wortmannin
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4.1.11 GSK-3β (Ser9) 
GSK phosphorylation after 10 min of reperfusion is demonstrated in Figure 
4-11.  An increase in GSK phosphorylation occurred in the RPO+Wn group when 
compared to the RPO group (115.6  1.3 pixels vs 95.24  4.5 pixels; p0.01).   
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Figure 4-11:  The effect of RPO-supplementation and Wortmannin 
administration on GSK phosphorylation in hearts subjected to 
ischaemia/reperfusion (n=3-7 per group) (mean ± SEM) (# p<0.01 for 
indicated groups) 
C = Control; RPO = Red Palm Oil; Wn = Wortmannin 
# 
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4.1.12 FKHR (Ser256) 
There was a significant decrease in FKHR phosphorylation in the RPO+Wn 
group when compared with the RPO group (73.00 ± 14.1 pixels vs 130.9 ± 3.5 
pixels; p0.05) (Figure 4-12).  The phosphorylated form of FKHR is exported 
from the nucleus, implying that no FKHR proteins can be transcribed.  RPO 
caused an increase in the phosphorylation of FKHR, whereas wortmannin 
decreased it.   
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Figure 4-12:  The effect exerted by RPO-supplementation and 
Wortmannin administration on FKHR phosphorylation in hearts subjected 
to ischaemia/reperfusion (n=3-7 per group) (mean ± SEM) (*p<0.05 for 
indicated groups) 
C = Control; RPO = Red Palm Oil; Wn = Wortmannin 
*
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Cleaved Caspase-3 (Asp175) 
Wortmannin significantly increased caspase-3 cleavage compared with the 
control group (56.27 ± 3.63 pixels vs 38.21 ± 4.14 pixels; p<0.05).  Furthermore, 
wortmannin also caused a significant increase in caspase-3 cleavage in the RPO 
group compared with the RPO control group (59.79 ± 2.1 pixels vs 26.75 ± 2.6 
pixels; p<0.001).  
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Figure 4-13:  The effect exerted by RPO-supplementation and Wn 
administration on the cleavage of caspase-3 in hearts subjected to 
ischaemia/reperfusion (n=3-7 per group) (mean ± SEM) (* p<0.05 and $ 
p<0.001 for indicated groups) 
C = Control; RPO = Red Palm Oil; Wn = Wortmannin
*
$
Stellenbosch University  http://scholar.sun.ac.za 
  56
4.1.13 Cleaved PARP (Asp214) 
There was an increase in cleaved PARP Figure 4-14 in the control+Wn 
group when compared to the control group (98.9 ± 9.3 pixels vs 42.12 ± 7.0 
pixels; p0.01).  PARP cleavage was significantly reduced in the RPO+Wn group 
compared with the control wortmannin group (98.9 ± 9.3 vs 50.23 ± 6.9 pixels; 
p0.001).  Wortmannin increased the cleavage of PARP while RPO inhibited the 
cleavage.  
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Figure 4-14:  The cleavage of PARP in hearts subjected to 
ischaemia/reperfusion that received RPO-supplementation and 
Wortmannin administration (mean ± SEM) (n=3-7 per group) (# p<0.01 and $ 
p<0.001 for indicated groups) 
C = Control; RPO = Red Palm Oil; Wn = Wortmannin 
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Chapter 5 DISCUSSION 
Cardiovascular disease is a major cause of death in the modern world (Ho 
et al., 1993).  Although previous studies consistently showed an inverse 
relationship between RPO consumption and ischaemia/reperfusion injury, the 
mechanism of the beneficial action of RPO remains to be elucidated.  
Biochemical evidence from previous studies suggests that PKB/Akt 
phosphorylation might induce an underlying protective mechanism (Esterhuyse 
et al., 2005; Bester et al., 2006; Engelbrecht et al., 2006; Kruger et al., 2007).  
However, the exact mechanism has not been elucidated.  Therefore, the aim of 
this study was to determine which up and downstream signalling peptides 
associated with the PKB/Akt pathway are possibly involved. 
 
5.1 Effect of RPO and Wortmannin on post-ischaemic 
functional recovery 
RPO-supplementation did not induce a better recovery in CF, HR and 
LVDevP during reperfusion.  The CF flow parameter was used to determine if 
there was a difference in bloodflow to the heart during RPO-supplementation.  It 
was determined in this study that RPO-supplementation did not increase the 
bloodflow to the heart.   
HR and LVDevP are used to determine the function of the heart.  However, 
to measure the mechanical function of the heart, it must combine the speed of 
contraction as well as the strength of contraction.  To measure this, RPP was 
measured, which is a scientifically excepted term for mechanical function.  
Individually, HR and LVDevP did not show significant differences in recoveries 
during reperfusion.  However, when combined, the measurement of RPP showed 
significant differences in recoveries during reperfusion.   
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  It was demonstrated in the current study that RPO-supplementation 
offered significant protection against ischaemia/reperfusion induced injury in the 
Langendorff-perfused rat heart model, during 10 min into reperfusion.  This can 
be concluded from the increased percentage RPP recovery in the RPO-
supplemented hearts.  After 10 min, the significance of the protection was lost.  
This protection is in agreement with previous studies that showed dietary RPO-
supplementation led to improved functional recovery after ischaemia in normal 
and hypercholesteroleamic diets (Esterhuyse et al., 2005; Engelbrecht et al., 
2006; Esterhuyse et al., 2006; Kruger et al., 2007; Bester et al., 2006).   
A better functional recovery was not seen in the CF and HR of the RPO-
supplemented and Wn perfused hearts.  An unexpected finding was that 
wortmannin perfusion improved functional recovery in the RPO + Wn treated 
group when compared to the control and the RPO group.  This was seen in the 
LVDevP (5 & 15 min) and the RPP (5 &15 min).  The combination of dietary RPO 
and wortmannin given before ischaemia afforded better cardioprotection during 
ischaemia and reperfusion, than the RPO-supplementation alone.  This is 
unexpected, because wortmannin is a PI3-kinase inhibitor, and activation of the 
PKB/Akt pathway is thought to be PI3-K-dependent. The PKB/Akt pathway is a 
pro-survival pathway.  Therefore, inhibition of this pathway is normally associated 
with increased ischaemic/reperfusion injury.   
It has previously been shown that hyperthemia-induced PKB/Akt activation 
was abrogated by wortmannin.  This indicates that in the heart, hyperthermia-
induced activation of PKB/Akt is predominantly PI3-kinase-dependent (Shinohara 
et al., 2006).  Therefore, when PI3-kinase is inhibited by wortmannin, the 
PKB/Akt pathway would be inhibited and that the function and viability of the cells 
should be reduced.  However, our results indicate that RPO-supplementation 
reversed wortmannin’s detrimental effect to such an extent that the myocardial 
functional recovery was far better than with RPO alone.  To our knowledge, no 
literature is available on the effects of fatty acids or other components of RPO on 
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wortmannin.  We can therefore only speculate that some component of RPO may 
counteract the detrimental effect of wortmannin induced PI3-K inhibition. 
  
5.2 Effect of RPO and Wortmannin on PI3-Kinase (p85) 
induction 
The novel mechanical results led us to study the effects of RPO and 
wortmannin on the signalling mechanisms that might be involved.   
Although there was a decrease in PI3-K induction when wortmannin alone 
was added to the perfusate, it was not significant.  This can be ascribed to the 
time the sample was taken.  Since PI3-K is activated in the cell membrane it 
might be speculated that the activation was at a much earlier time point and 
returned to basal levels when the sample was taken.  However, when 
wortmannin and RPO was administered together, there was a significant 
decrease in PI3-K induction.   
 
5.3 Effect of RPO and Wortmannin on PDK 
phosphorylation 
In our study, we observed no significant differences in PDK-1 phosphorylation 
due to RPO-supplementation and wortmannin administration.  PDK-1 is known to 
phosphorylate PKB/Akt (Anderson et al., 1998).  PDK-1 expression does not 
affect PKB/Akt Ser473 phosphorylation, but it is involved in PKB/Akt Thr308 
phosphorylation (Yamada et al., 2001).  The fact that RPO did not influence 
PDK-1 levels indicates that RPO does not influence the PKB/Akt pathway 
through PDK-1. 
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5.4 Effect of RPO and Wortmannin on PKB/Akt 
phosphorylation 
Wortmannin had a significant inhibitory effect on PKB/Akt Ser473 
phosphorylation.  This is in contrast to what was found by Engelbrecht and co-
workers, (2005), who reported that wortmannin inhibited PKB/Akt Thr308 but not 
PKB/Akt Ser473 phosphorylation.  Since wortmannin is a known PI3-kinase 
inhibitor, we can speculate that in this model, PI3-kinase-dependent activation of 
PKB/Akt was achieved through the PKB/Akt Ser473 phosphorylation site.  
Interestingly, in the RPO + wortmannin group, Ser473 phosphorylation returned to 
basal levels.  Wortmannin’s inhibitory effects were thus overridden by RPO.   
There were no differences in Thr308 phosphorylation with either RPO-
supplementation or with wortmannin administration.  This might be attributed to 
the lack of effect on PDK-1, as PDK-1 is known to phosphorylate PKB/Akt Thr308, 
but not PKB/Akt Ser473. 
RPO did not induce an increase in PKB/Akt phosphorylation in our model.  
This is in contrast with the findings from a previous study which showed that 
RPO treatment led to an increased phosphorylation of PKB/Akt during 
reperfusion (Engelbrecht et al., 2006).  Our study suggests that the protective 
effects of RPO may also be mediated through another pathway.  These 
differences may also be due to differences in study design.  In our study we used 
a 10 times higher dose of RPO than the above mentioned study.  We also used 
commercial available Carotino Premium RPO instead of the RPO baking fat.  
There was also a difference in the duration of supplementation.  We 
supplemented rats for 4 weeks, while Engelbrecht et al., (2006) fed rats with 
RPO for 6 weeks.  In our study the Langendorff perfusion system was used while 
in the study of Engelbrecht et al., (2006) a working heart system was used    
Although RPO caused an increase in Thr308 phosphorylation, it was not 
significant.  This can be ascribed to the small sample size.  Most of the literature 
suggests that PKB/Akt pathway is regulated by phospholipids.  However, there 
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are a few reports that suggest that mediators such as isoproteronol (Moule et al., 
1997) and cAMP (Sable et al., 1997; Filippa et al., 1999) may also be involved 
with PKB/Akt activation in a PI3-kinase-independent fashion.  It is thus possible 
that there may be additional protective mechanisms other than the PI3-kinase 
pathway.  Examination of C. elegans revealed a kinase that is homologous to 
PDK-1, but which does not have the phospholipids-binding PH domain.  This 
PDK-1 related enzyme is capable of activating the PKB/Akt kinase in a manner 
similar to a PI3-kinase-independent pathway (Li et al., 2001).  This novel kinase, 
PIAK (phospholipids independent Akt/PKB kinase), is only capable of 
phosphorylating the Thr308 residue, which might also explain the increase in 
Thr308 phosphorylation in our results. 
PIAK is not inhibited by wortmannin, thus the activity of PIAK kinase is 
independent of PI3-kinase.  PIAK also induces one of the forkhead transcription 
factors, AFX.  The mechanism through which PIAK interacts with PKB/Akt 
remains unresolved (Li et al., 2001).   
Although RPO-supplementation increased functional recovery, it was not 
associated with increased PKB/Akt total phosphorylation.  This is contrary to 
previous studies that showed that RPO did indeed activate the PKB/Akt pathway 
(Engelbrecht et al., 2005).  This might be due to technical differences between 
the studies as mentioned earlier.   
 
5.5 Effect of RPO and Wortmannin on GSK 
phosphorylation 
Activated PKB/Akt phosphorylates and inactivates glycogen synthase 
kinase on Ser9 (GSK-3) (Downward, 2004), and this inactivation leads to 
activation of glycogen synthase (Cross et al., 1995; Van Weeren et al., 1998).  
The activation of glycogen synthase contributes to glycogen synthesis and the 
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uptake of glucose from the blood.  Thus, PKB/Akt is also a key regulator of 
glycogen metabolism.   
We observed an increased GSK phosphorylation when the RPO group was 
supplemented with wortmannin.  Since the phosphorylation of GSK actually leads 
to the inactivation of the enzyme, we can conclude that RPO + wortmannin 
inactivated GSK, which leads to an increased glycogen synthase activity, which 
in turn leads to increased glycogen synthesis.  Glycogen is a storage form of 
glucose.  Alterations in glycogen metabolism and glucose utilization may 
contribute to loss of cardioprotection in stressed hearts.  It has been reported that 
a poor functional recovery is associated with an acceleration of glycolysis 
(Jaswal et al., 2006).  Glycogen accumulation may be beneficial and also lessens 
the potential for glycolysis (Henning et al., 1996; Russell et al., 1997).  Thus, 
increased glycogen synthesis leads to glycogen accumulation, which may be 
protective to the heart.  It was found that glucose from glycogen is preferentially 
oxidized compared with exogenous glucose (Henning et al., 1996) under 
normoxic conditions. 
The RPO + wortmannin possibly had a protective effect through GSK 
phosphorylation.  This can either be attributed to the increased phosphorylation 
of PKB/Akt Ser473, also seen with RPO + wortmannin, or a whole different 
protective pathway.  Inhibitors of the protein kinase C (PKC) family of kinases 
have been used to demonstrate that these enzymes are likely to play a key role 
in GSK-3 phosphorylation (Vilimek and Duronio, 2006). 
 
5.6 Negative regulation of PKB/Akt 
PTEN exerts a negative regulatory effect on PKB/Akt.  PTEN reduces the 
production of the messengers that leads to the activation of PKB/Akt (Haas-
Kogan et al., 1998; Maehama & Dixon, 1998; Stambolic et al., 1998).  PTEN 
exerts the same inhibitory effect as wortmannin on PI3-kinase activity (Kim et al., 
2002).  Therefore, PTEN negatively influences PKB/Akt activity.   
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In our study, we found that wortmannin increased PTEN phosphorylation 
and inhibited PI3-K induction.  These results confirm the findings of other studies 
(Yano et al., 1993; Tong et al., 2000).  The action of PI3-kinase on PKB/Akt is 
thus opposed by PTEN.   
PTEN negatively regulates PI3-kinase-dependent signaling of PKB/Akt 
(Barthel and Klotz, 2005).  The RPO + Wn group had a PTEN phosphorylation 
similar to that of the control and RPO group, indicating that RPO counteracts the 
effect of wortmannin, and exerts a protective effect on the myocytes.  
Thus, RPO exerts an inhibitory effect on PTEN in the absence of PI3-
kinase, and thus lessens the negative regulatory effect that PTEN have on the 
PKB/Akt pathway. 
   
5.7 Effect of RPO and Wortmannin on anti-apoptotic 
mechanisms 
The forkhead family (FKHR and FKHRL1) is a substrate of PKB/Akt and is 
phosphorylated by PKB/Akt (Nakae et al., 1999; Brunet et al., 1999; Rena et al., 
1999; Guo et al., 1999).  Because PKB/Akt negatively regulates factors that 
promote the expression of death genes, like the forkhead family of transcription 
factors, PKB/Akt activation exerts a prosurvival effect.  When PKB/Akt 
phosphorylates forkhead transcription factors, they are exported from the nucleus 
(Biggs et al., 1999), accumulate and are confiscated by proteins in the cytoplasm 
(Brunet et al., 1999).   
It was observed that RPO-supplementation induced significant increased 
phosphorylation of FKHR.  The suppressive effect of RPO on the expression of 
death genes may be associated with the increased post-ischaemic functional 
recovery observed in the RPO group.  It would appear that RPO-supplementation 
had a negative effect on the expression of death genes, whether through 
PKB/Akt activation or not.   
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Wortmannin caused a decreased phosphorylation of FKHR in the RPO-
supplemented hearts, which means that there were fewer FKHR transcription 
factors being exported from the nucleus, and thus that more death genes 
transcribed.  This is to be expected with wortmannin treatment, as wortmannin 
inhibits PI3-kinase (Yano et al., 1993; Tong et al., 2000), which inhibits the pro-
survival PKB/Akt pathway.    
PKB/Akt also functions to promote cell survival through phosphorylation and 
inactivation of pro-apoptotic proteins such as Bad, caspase-9, and possibly Apaf-
1 (Datta et al., 1997; Del Peso et al., 1997; Cardone et al., 1998; Zhou et al., 
2000).  PKB/Akt activation leads to the NF-B activation of the transcription of 
anti-apoptotic genes (Ozes et al., 1999; Romashkova and Makarov, 1999).  It is 
therefore possible that RPO might also be protective through one of these 
pathways.   
5.8 Effect of RPO and Wortmannin on Caspase cleavage 
The activation (thus the cleavage) of caspases is a key step in the initiation 
of apoptosis.  Caspases induces apoptosis by cleaving and inactivating cellular 
substrates, which play an essential role in maintaining cell viability (Nicholson, 
1996).  Apoptosis results from the activation of caspases in a cascade-like 
fashion (Cryns and Yuan, 1998; Thornberry and Lazebnik, 1998) and can be 
inhibited by increased PKB/Akt activation (Sabbatini and McCormick, 1999). 
A significant increase in caspase-3 cleavage was observed in the 
wortmannin perfused groups compared with the control groups.  Wortmannin is 
known to increase caspase-3 cleavage during ischaemia/reperfusion induced 
injury (Engelbrecht et al., 2004).  RPO could not counteract wortmannin’s pro-
apoptotic effect.  Interestingly, this increased caspase-3 cleavage induced by 
wortmannin does not correlate with the improved functional recovery in the 
RPO+wortmannin group.   
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5.9 Effect of RPO and Wortmannin on PARP cleavage 
PARP is a cellular protein that is specifically cleaved during apoptosis 
(Kaufmann et al., 1993).  The presence of cleaved PARP is thus an indication 
that apoptosis is already in progress.  Wortmannin administration caused an 
increase in the PARP cleavage.  This is to be expected, as wortmannin inhibits 
PI3-K (Yano et al., 1993; Tong et al., 2000), which in turn inhibits PI3-kinase-
dependent PKB/Akt activation.  Thus, wortmannin treatment is associated with 
reduced cell viability.  RPO caused the PARP cleavage to return to basal levels, 
indicating that RPO overrides wortmannin’s detrimental effects. This finding is 
associated with increased functional recovery in the RPO + wortmannin group. 
  
5.10 Conclusion 
RPO in conjunction with wortmannin improved reperfusion functional 
recovery in the reperfused rat heart.  The precise manner in which RPO and 
wortmannin influences cellular signalling is not yet clear, but it would appear that 
it might be related to reduced PTEN phosphorylation and increased PKB/Akt 
Ser473 phosphorylation which was associated with decreased PARP cleavage, 
thus attenuating apoptosis in our model. 
Although not all the cellular signalling pathways are yet clear, it is possible 
that RPO may also induce its protection through other pathways, such as the 
MAPKs or the PKC pathways.  The results obtained in the present study thus 
suggest that RPO in conjunction with wortmannin might offer an alternative 
strategy to protect the heart against ischaemia/repefusion-induced injury. 
The prevention of CHD in society remains a challenge and only a few drug 
therapies have convincingly reduced the risk of heart failure. Dietary intake of 
RPO in patients with a prior myocardial infarction is a low-cost and a low-risk 
intervention and it is time for clinicians to give increased attention to the 
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beneficial effects of RPO and translate this experimental evidence into clinical 
practice. 
Stellenbosch University  http://scholar.sun.ac.za 
 67
Chapter 6 FINAL CONCLUSION AND FUTURE     
DIRECTIONS 
We can conclude that Carotino Premium RPO-supplementation in 
conjunction with wortmannin perfusion did protect against 
ischaemia/reperfusion induced injury in the isolated Langendorff perfused 
rat heart.  We also conclude that RPO-supplementation and wortmannin 
administration influenced the PI3-K pathway; however, we are not sure 
through which regulatory proteins it exerted its effects.  It is possible that 
another pathway, like MAPKs or PKC might be involved in the protection 
induced in this model.  For future studies it would be advisable to look at 
RPO’s affect on these pathways and other proteins involved in PKB/Akt 
pathway modulation, in order to further elucidate the precise mechanism 
through which RPO and wortmannin protects against ischaemia/reperfusion 
induced injury.   
 
Chapter 7 RESERVATIONS OF THE STUDY 
In our study we showed that hearts from rats supplemented with RPO did 
have a better functional recovery, although it was only seen at the 10 min 
timepoint. After 10 min, the significance of the protection was lost.   An 
important possible explanation for this might be that the SEMs were too big 
in the RPO + Wn group.  When individual comparisons were done between 
the RPO-supplemented group and the control group, significant differences 
were found throughout reperfusion, but because it is not scientifically 
correct, this measure of statistics cannot be used.  This protection that was 
seen at 10 min in this study is similar to results from other studies 
(Esterhuyse et al., 2005; Bester et al., 2006).  However, we found that the 
effect of RPO on cellular signalling was different to what these studies 
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found (Engelbrecht et al., 2006).  These differences may be explained by 
the following critical issues.   
A possible explanation might be that the sample sizes are too small, and if 
the numbers in each group were increased, a significant difference might be 
found.  In our study, rats were supplemented with 2 ml Carotino Premium 
RPO per day for 4 weeks.  In the above mentioned studies, rats were 
supplemented with 0.2 ml baking fat RPO for 6 weeks.  The differences in 
feeding times might have had an influence on our results. The differences in 
types of oils might have had an influence.  We used Carotino Premium RPO 
as it is the commercially available oil.  The baking fat used in the 
abovementioned studies is a much more concentrated form of RPO than 
the Carotino Premium RPO that we used.  The differences in RPO dosages 
between this study (the supplier suggested the use of a higher dose in this 
specific study) and the previous studies might explain the slight differences 
in outcome of results.  These data imply that more is not necessarily better, 
and therefore our results also suggest that future studies should include a 
dose response study.  In our study we used the Langendorff perfusion 
model, whereas the above mentioned studies used the working rat heart 
model.  The working rat heart model is a more physiological system, 
especially when mechanical function is considered.  Our study focused 
more on the effect of RPO on cellular signalling and therefore we used the 
Langendorff perfusion system.     
For future studies, these aspects might be brought into consideration. 
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